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Abstract 
The homeobox gene goosecoid is expressed in the Spemann organizer 
tissue of gastrulating vertabrate embryos, and in the craniofacial region and 
appendicular skeleton during organogenesis. The goosecoid knockout mutant 
mause revealed defects related to the second phase of expression. ln this study, 
new goosecoid expression sites in the developing trachea and external genitalia, 
and in the developing shoulder and hip joint with their associated Iigaments and 
muselas were discovered. goosecoid null mutant mice were found to display 
abnormalities in the forming trachea, appendicular skeleton and genital region 
related to these sites of gene expression. 
Same aspects of the goosecoid null phenotype, such as the malformations of 
the middle ear, bear striking similarities to defects caused by retinoic acid (RA) 
treatment of embryos, suggesting that goosecoid might mediate specific taratagenie 
RA effects. Such a relation was investigated at two time points in development. 
Following treatment of mause embryos in vivo at embryonie day (E) 8 + 5 h, 
goosecoid was specifically affected in branchial arches I and II at E10.5. 
Expression was either reduced to background Ieveis or restricted to the branchial 
cleft region. This change in goosecoid gene expression correlated with a lass of 
middle ear ossicles and a partial or complete deletion of the tympanic ring, 
supporting a role for goosecoid in executing the RA taratagenie effects. 
Analysis at E1 0.5, a second RA-sensitive time window for mause embryos, 
revealed that goosecoid was down-regulated 4 h after treatment. However, 
goosecoid expression returned to normal 24 h following treatment. BMP-4, a 
member of the transforming growth factor ß (TGF-ß) superfamily, was analysed 
because BMP-4 was shown to be an antagonist of goosecoid in frag gastrula 
embryos, and because BMP-4 plays a role in bone formation, the primary target of 
taratagenie RA action. Like goosecoid, BMP-4 was repressed by RA 4 h after 
treatment at E10.5, and expressionwas normal again after 24 h. 
The mechanism of down-regulation of both goosecoid and BMP-4 was 
studied in mause teratocarcinoma cells, using transient transfections of luciferase 
reporter gene constructs. A 4.8 kb goosecoid promoter fragment was down-
regulated by RA in P19 cells. Repression was dependant on the co-transfection of 
the retinoid X receptor (RXR). RXRa was the strengest isoform in mediating this 
effect, followed by RXRß and RXRy. 9-cis RA was more potent as a Iigand compared 
to all-trans (t) RA. 8oth RAR and RXR specific ligands were active in repression of 
goosecoid, with the RXR specific compound SR11237 being more efficient. 8MP-4 
was analyzed in F9 cells which express the gene endogenously. 8oth tRA and 9-
cis RA treatment resulted in a down-regulation of 8MP-4 mRNA 4 h after treatment 
of cell cultures. While tRA, 9-cis RA, and the RAR specific Iigand AmBO were able to 
repress 8MP-4 efficiently within 24 h of RA treatment, SR11237 had no effect, 
suggesting that down-regulation of 8MP-4 by RA did not require activition of RXR 
homodimers. 
To further investigate the role of goosecoid and BMP-4 in mediating RA 
teratogenicity, geneexpressionwas analyzed in RXR« null mutant mouse embryos 
following RA treatment. This mutant was chosen because it was shown to be 
resistant to RA teratogenic effects specifically in the limbs, and because goosecoid 
and 8MP-4 both are expressed in developing limbs and play a role in limb 
development. While goosecoid was equally repressed in wildtype and RXR« 
mutant embryos, 8MP-4 showed remarkable differences. Among three other 
homeobox genes analyzed in this part of the study, Msx1 and Hoxd-11, like 
goosecoid were unaltered, whereas Msx2 was not repressed in RXR« null mutant 
embryos. 
ln summary this work further establishes the roJe of goosecoid as an 
important regulator of mouse development during organogenesis stages, in 
particular in the developing limbs. The data presented show that goosecoid and 
8MP-4 both play a role in mediating the teratogenic effects of RA. 
Das homeoboxgen goosecoid: Expression in der 
embryonalen entwichlung, loss-of-function phänotyp 
und seine regulation durch retinsäure 
Zusammenfassung 
Das Homeoboxgen goosecoid wird im Spemann Organisator während der 
Gastrulation, in der kraniofazialen Region sowie im appendikularen Skelett 
während der Organogenese des Wirbeltierembryos exprimiert. Die goosecoid 
knockout Mutante weist Defekte auf, die in Beziehung zur zweiten Phase der 
goosecoid Expression stehen. Diese Arbeit zeigt neue goosecoid Expressionsorte 
wie die sich entwickelnde Trachea, die äußeren Genitalien, die sich entwickelnden 
Schulter sowie das Hüftgelenk und die damit verbundenen Ligamente und 
Muskeln. Bei den goosecoid Nullmutanten-Mäusen konnten entsprechend den 
Expressionsorten Abnormalitäten in der sich bildenden Trachea, im appendikularen 
Skelett und in der Genitalregion aufgezeigt werden. 
Einige Aspekte des goosecoid Nullphänotyps, wie die Mißbildung des 
Mittelohrs, zeigen auffallende Ähnlichkeiten mit Defekten, wie sie bei mit Retinsäure 
(RA) behandelten Embryos auftreten. Diese Tatsache deutet daraufhin, daß 
goosecoid bestimmte teratogene Effekte der Retinsäure vermittelt. Dieser 
Zusammenhang wurde an zwei Zeitpunkten in der Entwicklung untersucht. 
Nach in vivo Behandlung von acht Tage und fünf Stunden alten 
Mausembryos war die goosecoid Expression spezifisch in den Kiemenbögen I und 
II am Tag 10,5 p.c. (post coitum) betroffen. Die Expression war entweder nicht mehr 
nachweisbar oder auf die Kiemenspaltenregion beschränkt. Die Änderung der 
goosecoid Expression korreliert mit dem Verlust der Mittelohrknöchelchen und dem 
teilweisen oder kompletten Verlust des tympanischen Ringes. Dies läßt darauf 
schließen daß goosecoid RA teratogene Effekte vermittelt. 
Analysen von 10,5 Tage alten Embryos (E10,5), einem zweiten RA sensitiven 
Zeitfenster in der Mausembryogenese, zeigten, daß die goosecoid Expression vier 
Stunden nach RA-Behandlung herabreguliert wurde und 24 Stunden nach RA-
Behandlung zum Normalwert zurückkehrte. 
Weiterhin wurde BMP-4, ein Mitglied der transformierenden 
Wachstumsfaktoren ß (TGF-ß) Superfamilie, analysiert. ln der Froschgastrula wurde 
für BMP-4 gezeigt, daß es antagonistisch zu goosecoid wirkt. Außerdem spielt BMP-
4 eine Rolle bei der Knochenentwicklung, dem primären Ziel teratogener RA-
Wirkung. Die Versuche zeigten, daß BMP-4 wie goosecoid vier Stunden nach RA-
Behandlung am Tag 10,5 reprimiert wurde, nach 24 Stunden war die normale 
Expression wieder vorhanden. Zur Klärung des Mechanismus der 
Herunterregulierung von goosecoid und BMP-4 wurde mittels transienter 
Transfaktionen von Luziferasereporter-Konstrukten in Mausteratokarzinomzellen 
untersucht. Ein 4,8 kb goosecoid Promotorfragment wurde durch RA in P19 Zellen 
herunterreguliert. Diese Repression war abhängig von der Kotransfektion von 
Retinoid-X-Rezeptor (RXR). Der Effekt wurde am stärksten durch die Isoform RXRa 
vermittelt, gefolgt von RXRß und RXRy. Die 9-cis RA war der stärker aktivierende 
Ligand im Vergleich zum all-trans (t) Isomeren. Seide für RAR und RXR spezifische 
Liganden konnten goosecoid reprimieren, wobei die RXR spezifische Komponente 
SR11237 goosecoid effizienter reprimierte. BMP-4 wurde in F9-Zellen analysiert, 
welche das Gen endogen exprimieren. tRA und 9-cis RA Behandlung resultierte in 
Herunterregulierung von BMP-4 mRNA vier Stunden nach Behandlung der Zellen. 
Während tRA, 9-cis RA und der RA spezifische Ligand AmBO Bmp-4 effizient 
innerhalb 24 Stunden nach RA Behandlung reprimierten, hatte SR11237 keinen 
Effekt. Daraus läßt sich folgern, daß die Herunterregulierung von BMP-4 durch RA 
keine Aktivierung von RXR Homodimeren benötigt. 
Zur weiteren Untersuchung der Rolle von goosecoid und BMP-4 bei der 
Vermittlung der RA Teratogenität wurde die Genexpression von RXRa Nullmutanten 
Mausembryos nach RA Behandlung analysiert. Diese Mutante wurde aus zwei 
Gründen gewählt, erstens ist sie resistent gegen RA vermittelte teratogene Effekte 
speziell in den Extremitäten und zweitens werden goosecoid und BMP-4 in den 
sich entwickelten Extremitäten exprimiert. Während goosecoid gleichermaßen im 
Wildtyp und in RXRa Mutanten Embryos reprimiert wurde, zeigte BMP-4 
bemerkenswerte Unterschiede. Unter drei anderen analysierten Homeoboxgenen 
in diesem Teil der Arbeit war die Expression von Msx1 und Hoxd-11 wie die von 
goosecoid unverändert, wohingegen Msx2 in RXRa Null mutanten Embryos nicht 
reprimiert wurde. 
Die Arbeit bestätigt zusammenfassend die Rolle von goosecoid als wichtigen 
Regulator in der Mausentwicklung während der Organogenesestadien 
insbesondere in den sich entwickelnden Extremitäten. Die präsentierten Daten 
zeigen, daß goosecoid und BMP-4 eine Rolle bei der Vermittlung teratogener 
Retinsäureeffekte spielt. 
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Introduction 1 
1. lntroduction 
The development of an animal from the fertilized egg has been a source of 
wonder throughout human history (Gilbert, 1997). Many scientists strived to uncover 
the mechanisms behind embryonie development. ln the last two decades, with the 
advent of molecular techniques, such as cloning of developmental master genes 
and their functional analysis by gene targeting or transgenic approaches, it became 
possible to unravel molecular mechanisms underlying development. Among these 
genes is a large family called homeobox genes. Individual genes are often 
conserved from invertebrates to vertebrates (from Drosophila to humans). 
Homeobox genes encode transcription factors which can regulate complex genetic 
programs. They bind to DNA through the homeodomain, a 60 amino acid helix-
loop-helix motif. 
1.1 The early deveiopment of vertabrate embryos: Spemann 
organizer and gastrulation 
Early development has been particularly weil studied in amphibian embryos. 
Fertilization initiates a cytoplasmic rotation. This so-called cortical rotation is 
believed to locally activate substances that are required for development on the 
prospective dorsal side of the embryo (Gerhart et al., 1989). Subsequently, the 
zygote undergoes a series of synchronaus cleavage divisions leading to the 
formation of the blastula (Gilbert, 1997). The induction of mesoderm begins at about 
the 32-cell stage (Jones and Woodland, 1987). Prior to gastrulation, the embryo 
consists of two primary germ layers: the pigmented animal hemisphere composed 
of prospective ectoderm, and the vegetal hemisphere consisting of prospective 
endoderm (Christian and Moon, 1993). At the onset of gastrulation, the third germ 
layer, the mesoderm, differentiales from ectoderm cells which reside in the 
equatorial (or marginal zone) region of the embryo in response to inductive signals 
provided by underlying endodermal cells (Nieuwkoop, 1969). During gastrulation, 
the cells of the marginal zone invaginate into the embryo through a slit-like opening 
forming on the dorsal site: the so-called dorsal lip. Near the end of gastrulation, 
dorsal mesoderm cells induce the overlying ectoderm to form neural tissue. 
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Embryos then enter neuralation. The mechanisms underlying these inductive 
events were studied by tissue explant and grafting experiments in amphibian 
embryos. There are two well-defined centers in the early amphibian embryos: the 
Nieuwkoop center and the Spemann organizer. Signals ernerging from the 
Nieuwkoop center induce formation of mesoderm tissue in the Xenopus dorsal lip, 
i.e. the induction of formation of the Spemann organizer. Transplantation of the 
dorsal lip, the region where gastrulation starts, into the ventral side of a host 
amphibian embryo induced the formation of a secondary body axis (Spemann, 
1924). The transplanted tissue, whose normal fate was to become head mesoderm 
and notochord, was able to recruit cells from the ventral side of the embryo and 
organize them into axial structures such as somites and neural tube. Therefore, 
Spemann named the dorsal lip the organizer. 
The Spemann organizer has three major properties: (1) its progeny forms the 
embryonie axial structures; (2) it recruits non-organizer cells to form axial or paraxial 
structures; and (3) it induces neural tissue. 
Structures functionally equivalent to the amphibian organizer have been 
identified in other vertebrates on the basis of their ability to produce a secondary 
axis when heterotopically grafted in young gastrulae. The organizer structure in the 
mouse is the so-called node, found at the anterior tip of the primitive streak (Bium et 
al., 1992; Beddington, 1994). ln chick, it is Hensen's node, located at the anterior 
end of the primitive streak of gastrulating embryos and partially derived from 
Koller's sickle (lzpisua-Belmonte et al., 1993). ln fish, the shield, a dorsal marginal 
structure, resernblas the dorsal blastopore lip of Xenopus (Shih and Fraser, 1996). 
The past several years have witnessed a very produclive search for 
molecules that are able to mirnie Spemann organizer activity, and for molecules 
active in dorsal and ventral mesoderm specification. The secreted signaling 
molecule Sone Morphorgenetic Protein 4 (BMP-4), a member of the transforming 
growth factor ß (TGFß) superfamily, specifies ventral mesoderm in Xenopus 
embryos. The dorsal mesoderm is characterized by the molecules that antagonize 
BMP-4 activity, such as chordin, noggin and follistatin. 
The secreted molecule chordin was cloned from a Xenopus dorsal lip library 
by differential screening (Sasai et al., 1994). This molecule is a potent dorsalizing 
factor that can induce twinned axis and can completely rescue axial development in 
embryos ventralized by UV radiation, a treatment that often abolishes the cortical 
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rotation. lts expression in the Spemann organizer can be activated by the organizer-
specific herneobox gene goosecoid. lnduction of chordin by activin, a TGFß-like 
signaling molecule active in mesoderm induction, requires de novo protein 
synthesis (Sasai et al., 1995). 
Two other organizer-specific secreted molecules, noggin and follistatin also 
have very streng neuralizing activity (Lamb et al., 1993; Hemmati-Brivanlou et al., 
1994). Each of these two secreted molecules can directly neuralize ectoderm 
explants in the absence of detectable mesoderm. Noggin protein itself mirnies the 
Spemann organizer in dorsalizing Xenopus mesoderm (Smith et al., 1993), 
respecifying lateral mesoderm tissues from lateral (blood mesoderm) to more 
dorsal fates (muscle, heart, pronephros). 
The dorsalizing and neuralizing activities of these three secreted molecules 
are obtained by antagonizing the ventral signaling molecule BMP-4 which instructs 
ectoderm to become epidermis and ventral mesoderm (Zimmerman et Ia., 1996; 
Sasai et al., 1995; Fainsod et al., 1997), Chordin, noggin and fol/istatin bind BMP-4 
with high affinity and prevent BMP-4 from binding to its cognate cell-surface 
receptors (Piccolo et al., 1996; Zimmerman et al., 1996; Fainsod et al., 1997). lt 
appears that the function of the signaling molecules and transcription factors from 
Spemann organizer is to inhibit the ventral signal BMP-4. Ectoderm cells become 
epidermis other than neural tissue unless BMP-4 activities are inhibited by signaling 
molecules from the Spemann organizer. 
The inhibition of BMP-4 activity on the dorsal side of the embryo is 
guaranteed through a genetic network. Activities emanating from the Nieuwkoop 
center induce the formation of the Spemann organizer. There the expression of 
goosecoid Ieads to the activation of chordin, which in turn antagonizes BMP-4, in 
concert with folfistatin and noggin. 
1.2 The homeobox gene goosecoid 
The herneobox gene goosecoid was the first gene cloned from a cDNA 
library derived from the dorsal lip tissue of Xenopus embryos (Biumberg et al., 
1991). lt was found tobe able to mirnie Spemann organizer activity in inducing a 
secondary body axis when goosecoid mRNA was misexpressed in the ventral side 
of early Xenopus embryo (Cho et al., 1992). After the Xenopus goosecoid gene was 
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identified, homologaus genes have been isolated from mause (Bium et al., 1992), 
chick (lzpisua-Belmonte et al., 1993), zebrafish (Stachel et al., 1993 and Schulte-
Merker et al., 1994) and human (Bium et al., 1994). Since its identification, this gene 
has been extensively studied, from expression pattern to gain- and loss-of-function 
experiments in different species, from early gastrulation to late organogenesis, the 
regulation by growth factors and the function of the protein itself in regulation of 
target genes. 
The expression pattern in early gastrula embryos in all vertebrates suggested 
a role for goosecoid in gastrulation. Expression data in Xenopus showed that 
goosecoid mRNA was located in the deep layer of the upper lip of the dorsal 
blastopore (Cho et al., 1991 ). This expression persists in the prechordal plate, a 
derivative of organizer tissue (Steinbeisser and De Robertis, 1993; Artinger et al., 
1997). The fate of these cells is to form mostly prechordal (head) mesoderm and 
notochord in later development (Keller, 1976; Slack, 1991 ). 
ln mause gastrula embryos, ln addition, goosecoid was found to be 
expressed in the early primitive streak mesoderm (Bium et al., 1992). goosecoid 
was expressed in the anterior mesoderm of gastrula embryos in a number of other 
vertabrate species (lzpisua-Belmonte et al., 1993; Stachel et al., 1993; Schulte-
Merker et al., 1994; Filosa et al., 1997). Microdissected mause goosecoid-
expressing cells from gastrulation embryos could elicit a new body axis when 
transplanted to the blastocyst of Xenopus early gastrula embryos (Bium et al, 1992). 
The results from these gain-of-function studies suggest that the goosecoid 
homeodomain protein plays a central role in executing Spemann's organizer 
phenomenon. 
However, goosecoid null mutant mice did not have a gastrulation phenotype 
(Rivera-Perez et al., 1995; Yamada et al., 1995). lnstead, these mice had a 
craniofacial phenotype related to the secend phase of goosecoid expression (Gaunt 
et al., 1993) at organogenesis stage. Those phenotypes include malformation of 
middle ear bones, lass of the tympanic ring and abnormalities of nasal cavaty and 
tongue. Lack of a gastrulation phenotype could be explained by compensation 
through other closely related genes. Two additional goosecoid related genes have 
indeed been isolated recently, GSX in chick (Lemaire et al., 1997) and gscl in 
rnouse (Galili et al., 1997; Schweickert and Blum, unpublished). lt is not known yet if 
these two genes play any role in gastrulation. Recently, it was found that goosecoid 
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and another organizer-specific gene, the winged-helix gene HNF-3ß, genetically 
interact in regulation of mouse gastrulation (Filosa et al., 1997). Removal of one 
copy of HNF-3ß in a goosecoid null mutant background results in early phenotypes, 
severe ventralization of the brain including forebrain in day E8. 75 embryos. These 
defects were accompanied by a loss or reduction of the expression of the midbrain 
organizer molecule fibroblast growth factor 8 (FGF-8 ), the signaling molecule shh 
important for notochord development; and the axon guidance molecule netrin. 
These phenotypes argue that goosecoid together with other genes is required for 
axial patterning during gastrulation. 
1.3 BMP-4 in embroygenesis 
ln the early development of vertabrate embryos goosecoid and BMP-4 mark 
dorsal and ventral signaling centers respectively. lnterestingly, they have been 
shown to antagonize each other in Xenopus early gastrula (Fainsod et al., 1994). As 
is the case for goosecoid, BMP-4 also plays important roles in the normal 
development of embryos at organogenesis stage (Hogan, 1996). 
ln mouse embryogenesis BMP-4 was demonstrated to be required for 
tormation of mesoderm (Winnier et al., 1995). At organogenesis stage, BMP-4 is 
required for the normal development of a number of organs. Ovarexpression ot 
BMP-4 in the chick limb bud Ieads to a dramatic increase in the volume ot cartilage 
elements, altered cartilage shapes and joint fusions (Duprez et al., 1996). A knock-
out of the BMP-4 antagonist noggin from mouse embryos results in cartilage 
hyperplasia of skeletons and joint fusions due to excess BMP activites (Brunet et al., 
1998). BMP-4 is also an important signaling molecule required for epithelial-
mesenchymal interactions and proper development of many organs, such as teeth 
(Vainio et al., 1993), hair follicles (Biessing et al., 1993), somites (McMahon et al, 
1998) and pituitary (Treier et al., 1998; Ericson et al., 1998). 
BMP-4 signaling is also required for interdigital apoptosis and scale 
formation (Zou et al., 1996; Ganan et al., 1996) and for apoptosis in the 
rhombencephalic neural crest (Graham et al., 1994). 
BMP-4 signaling initiates from the cell surface by interacting with two distinct 
serine/threonine kinase receptors (Massague and Weis-Garcia 1996; ten Dijke et 
al., 1996). Ligand binding induces the formation of a complex in which the type II 
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receptor phosphorylates and activates the type I receptor; this protein then 
propagates the signal by phosphorylating a family of signal transducers, the Smad 
proteins (Massague et al. 1997). There are three types of Smad proteins. Smad 1 
and its closely related members Smad5 and Smad 9 mediate BMP signaling (Graff 
et al., 1996; Hoodless et al., 1996; Lechleider et al., 1996; Liu et al., 1996; Thomsen 
1996; Yingling et al., 1996; Kretzschmar et al., 1997; Suzuki et al., 1997; Watanabe 
et al., 1997). These Smads get phosphorylated on serine residues at their carboxy-
terminal ends (SSXS motif) through the action of specific type I receptors (Macias-
Silva et al., 1996; Kretzschmar et al., 1997), and their phosphorylation Ieads to 
formation of a heteromeric complex with the second Smad class, which includes 
Smad4 in vertebrates (Lagna et al., 1996; Zhang et al., 1997). The tumor 
suppressor Smad4/DPC4 (Hahn et al., 1996) acts as a shared partner for both 
BMP-specific and TGF-ß/activin-specific Smads (Lagna et al., 1996; Zhang et al., 
1997) and plays an essential role as a transcriptional activator in the nucleus (Liu et 
al., 1997). Recently, a third class of Smads has been reported, whose members act 
as antagonists of these signaling pathways (Hayashi et al., 1997; lmamura et al., 
1997; Nakao et al., 1997; Topper et al., 1997; Tsuneizumi et al., 1997). 
1.4 Retinoic acid: a morphargen in development 
RA, a derivitive of vitamin A, plays a pivotal role in homeostasis and 
vertabrate embryogenesis. Pharmacological doses of both RA and synthetic 
derivitives of RA have been used for the treatment of several diseases of the skin 
(Wieder and Lowe, 1995) and a variety of cancers, including promyelocytic 
leukemia, breast cancer, carcinomas of the respiratory tract, and ovarian cancer 
(Hili and Grubbs, 1992; Hong and ltri, 1994). However, exogenaus RA is teratogenic 
to developing embryos. 
1.4.1 Retinoic acid and development 
Accumulating evidence suggests that RA is a natural morphogen in 
vertabrate embryonie development. RA in the chick limb was directly measured 
(Thaller and Eichele, 1987). Highly sensitive reporter genes controlled by RA-
inducible promoters have been used to assay indirectly for active retinoids. Mice 
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transgenic for these reporter genes reveal the presence of retinoids in the nervaus 
system and limbs during embryogenesis (Hogan et al., 1992; Balkan et al., 1992; 
Rossant et al., 1991 ). ln vitro assays have found active retinoids in early mouse 
embryos, in the posterior of the chick embryo (Chen et al., 1992) and in explants 
from the chick nervaus system (Wagner et al., 1992). 
More than fourty years ago it was noted that fetuses from rat mothers raared 
on vitamin A-deficient (VAD) diets exhibit severe congenital malformations known 
as the fetal VAD syndrome (Wilson and Warkany, 1948, 1949; Warkany et al., 1948; 
Wilson et al., 1953). These malformations include abnormalities of the eyes, 
respiratory tract, heart and great vessels, urogenital system and diaphragm, and 
cleft palate (Haie, 1933). Addition of retinol to the diet of VAD dams during 
pregnancy reversed nearly all of those malformations, a clear demonstration that 
vitamin A is critical for normal development. 
The cloning and study of retinoic acid receptors (RAR) and retinoic X 
receptors (RXR) greatly facilitated our understanding of the biological action of RA 
(Chambon, 1994; Mangelsdorf et al., 1994). RAR and RXR belang to the nuclear 
hormone receptor superfamily. These receptors act as Iigand dependent 
transcription factors by binding to RA response elements (RAREs) on DNA. tRA 
binds to only RARs, whereas 9-cis RA can bind both RAR and RXR (Leid et al., 
1992; Mangelsdorf et al., 1994). RAR and RXR form heterodimers on a RARE, which 
is an AGGTCA direct repeat spaced by two to three base pairs (Mangelsdorf and 
Evans, 1995). On direct repeats spaced by one basepair (DR1), RXR can bind as 
both a homodimer and as heterodimer with RAR. RXR is also an auxillary partner for 
other nuclear receptors, such as the thyroid hormone and vitamin D receptors 
(Giass, i 994). 
The highly diverse effects of RA signaling would be accounted for by the 
multiplicity of functionally distinct receptors (Leidet al., 1992; Chambon, 1994). This 
possibility has been tested in vivo by generating null mouse mutants for the various 
receptors (Li et al., 1993; Lohnes et al., 1993; Lufkin et al., 1993; Mandelsohn et al., 
1994). Single receptor mutant mice did not recapitulate the fetal VAD syndrome, 
suggesting a high degree of functional redundancy amongst the various RARs, but 
compound RAR mutant mice exhibited a large number of malformations (Lohnes et 
al., 1994), including abnormalities characteristic of the VAD syndrome. These 
evidences demonstrated that RA is the retinoid signaling molecule used during 
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development and that AARs are indeed transducers of this signal in vivo. A 
synergistic effect was observed in compound mutant mice bearing one null allele of 
RXR and one null allele of RAR, suggesting that RXRIRAR heterodimers are the 
functional units transducing the retinoid signal for a large number of RA-dependent 
processes. The same study indicated that RXRo: is the main RXR implicated in the 
developmental functions of AARs (Kastner et al., 1997). 
1 . 4. 2 Retinoic acid in anterior-posterior axis patterning 
After the initiation of gastrulation, the subdivision of the embryo along the 
anterior-posterior axis begins. Along the anterior-posterior body axis in early 
development, the homeobox gene otx2 defines the most anterior domain of the 
body, i.e. forebrain, and Hox genes pattern the body axis posterior to the domain of 
otx2. As with the homologaus Drosophila genes, the vertabrate Hox genes are 
expressed in a manner which is colinear with the organization of these genes in 
chromosomal clusters. The closer to the 3' of the cluster the genes are localized, the 
ealier and more anterior they are expressed along the anterior-posterior body axis. 
Loss-of-function mutations of Hox genes are often associated with anterior 
transformations of vertebrae, i.e., one of the posterior vertebra adopts the identity of 
a more anterior one. Surprisingly, the alterations to the axial skeletons of RAR 
mutant mice are homeotic and are similar to certian Hox gene loss-of-function 
phenotypes (Lohnes et al, 1994). The axial skeletons of RARy homozygotes and all 
RAR double-mutant combinations reported (o:ly, o:Iyo:2+/-, o:y, ß2y and o:ß2) exhibit 
homeotic transformations. The transformations are almost exclusively anterior 
transformations and are restricted to the cervical region. ln contrast, overexpression 
of Hox genes led to transformations to posterior structures (Krumlauf, 1993). 
Treatment of embryos with excess RA also resulted in posterior transformation, i.e., 
one of the anterior vertebra adopts the feature of a more posterior one. All of these 
data are consistant with the notion that embryonie RA positively regulates the 
expression of Hox genes in the posterior of the embryo. 
The first direct link between RA and the regulation of Hox genes came from 
investigations of the differentiation of teratocarcinoma cells (Colberg-Poley et al., 
1985; Breier et al., 1986). Studies with the human teratocarcinoma cell line NT2/D1 
demonstrated that many genes in all four Hox clusters were RA-inducible (Simeone 
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et al., 1990; Simeone et al., 1991) and that genes near the 3' end of the cluster are 
induced extremly rapidly by low concentrations of RA. With increasing distance from 
the 3' end of the cluster, the time and concentration of RA required for equivalent 
induction of a gene increases. Regulation of some Hox genes is direct because no 
new protein synthesis is required (Simeone et al., 1991 ). ln addition, RAREs were 
found downstream of the murine Hoxa-1 and human HoxA-1 genes and the murine 
and chick Hoxb-1 genes (Langston and Gudas, 1992) and Hoxd-4 (Moroni et al., 
1993; Pöpperl and Featherstone, 1993). Using lacZ reporter genes in transgenic 
mice, mutational analysis of specific RAREs 3' of both Hoxa-1 and hoxb-1 has 
suggested that these elements are involved in regulating aspects of early neural 
expression. Germline mutations in the Hoxa-1 3' RARE resulted in lower Ieveis of 
Hoxa-1 expession and a temporal delay in establishing its normal anterior 
boundary (Studer et al., 1998; Gavalas et al., 1998), strengthening the hypothesis 
that RA plays an important role in controlling early Hox expression in vivo and that it 
is involved in the patterning of the anterior and posterior body axes. 
1.4.3 RA and limb patterning 
A role for RA in normallimb development has been weil documented. RA has 
been implicated in limb patterning by experiments in which local application of RA 
Ieads to pattern duplications in the limb (Helms, 1994). The zone of polarizing 
activity (ZPA) in the posterior limb bud is able to pattern the posterior to anterior axis 
of the limb. Grafting of a ZPA to the anterior of another limb bud can result in 
duplicated digits. Application of RA can mirnie ZPA activity. Recently, shh was found 
to be the morphogen in the ZPA. Application of RA can induce the expression of shh 
(Helms, 1994). Direct evidence for a function of RA in limb patterning came from 
RARa.y double-mutant mice which showed defects in forelimb development, the 
majority of which involved the loss of anterior pattern elements, particularly the first 
digit, prepollex and radius (Mendelsohn et al., 1994). 
1.4.4 Teratogenic effect of RA on embryonie development 
Excess RA is detrimental to the development of vertabrate embryos. Embryos 
exposed to excess RA throughout the period of embryogenesis (i.e. from early 
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postimplantattion stages to the end of organogenesis) show abnormalities of many 
organ systems (Shenefelt, 1972). The taratagenie effect of RA an embryos is stage 
and dosage dependent. This reflects the effect of RA on different tissues and 
different developmental genes at different developmental stages of embryogenesis. 
Application of exogenaus RA to embryos at early developmental stage down-
regulates otx2 in forebrain and midbrain, causing a truncation of the head (Simeone 
et al., 1995), and it shifts Hox gene expression to a more anterior boundary causing 
Iack of identity of hindbrain and posterior transformation of cervical vertebra. 
One of the main targets of RA teratogenesis is bone development. For 
example, RA affects the development of the craniofacial skeleton, axial skeleton and 
limb lang bones. 
At the cellular Ievei, excess RA either inhibits neural crest cell migration or 
alters its migration pathway, depending on the embryonie stage when excess RA is 
applied (Thorogood et al., 1982; Webster et al., 1986; Pratt et al., 1987; Lee et al., 
1995; Gale et al., 1996; Malle, 1997). 
Excess RA can also trigger apoptosis, i.e., programmed cell death (Piedrafita 
and Pfahl, 1997; Li et al., 1998). Under normal conditions, apoptosis is a 
physiological phenomenon, whereas inhibition of apoptosis will Iead to tumor 
formation, and enhancement of apoptosis will result in teratogenesis in embryos. 
The apoptotic effect of RA may explain some of the taratagenie effects resulting from 
excess RA application. 
The primary effect of excess RA is alteration of normal expression of a 
number of transcription factors and matrix proteins. Four known mechanisms have 
been described to explain how excess RA can alter the expression of genes. 
First, as discussed before, excess RA can ectopically up-regulate target 
genes which contain RAREs in their regulatory sequence, like Hoxa-1 and Hoxb-1. 
Second, excess RA down-regulates a number of genes by squelching AP-1 
transcription factor binding to AP-1 response elements. These genes include 
stromelysin (Nicholson et al., 1990) and collagenase (Schüle et al., 1991 ). The 
transcription factor AP-1 is composed of Fos and Jun proteins (Bohmann et al., 
1987; Angel et al., 1988; Bos et al., 1988). Jun and Fes form heterodimers and bind 
to an AP1 binding site (TGAGTCA) to positively regulate expression of genes 
involved in cell division and proliferation (Curran and Franza, 1988; Hart et al., 
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1989; Vogt and Bos, 1989). This mechanism may explain why RA can Iimit cell 
growth, and possibly, malignant progression (Schüle et al., 1991 ). 
Third, excess RA in certain circumstances can Iead to degradation of the 
general transcription factor Sp1 (Piedrafita and Pfahl, 1997). The RA-induced 
degradation of Sp1 may have profound effects on the basal transcription of many 
genes. The promoter occupancy of Oct4 by Sp1 was lost after treatment of cells with 
RA, and the lass of the promoter occupancy by Sp 1 correlates with the down-
regulation of Oct4 by RA ( Minucci et al., 1996). 
Fourth, repression of Oct3/4 by RA is one of the examples that involves the 
up-regulation of the trans-repressors COUP~TFI and COUP-TFII. These two orphan 
nuclear receptors can compete with RAR and RXR for the binding to RARE with high 
affinity (Ben-Shushan et al., 1995). 
1.5 Aim of the study 
The main goal of this work was to investigate the possible correlation 
between the goosecoid gene function and RA teratogenicity because the goosecoid 
null mutant mice bear some resemblance to RA taratagenie effect. 
As a starting point, goosecoid expression at organogenesis stage was re-
investigated in detail between E10.5 and Ei6.5. ln the course of this analysis, new 
expression sites were discovered in the developing trachea, shoulder and hip joints 
and adductor muscles, and genitalia. Re-evaluation of the goosecoid null mutant 
mause led to the discovery of phenotypes related to the expression sites in trachea, 
proximal limb and adductor muscles. 
The possibility of goosecoid as a mediater of RA teratogenicity was analysed 
by three types of experiments. First, mause embryos were treated at E8 + 5 h with 
tRA. A correlation of alteration of goosecoid gene expression and lass of middle ear 
bones were found. Second, the immediate early effect of RA on goosecoid and 
BMP-4 expression in mause embryos was studied at another RA sensitive time 
window, E10.5. goosecoid was down-regulated 4 h after RA treatment of mause 
embryos. This down-regulation was transient since the expression pattern returned 
to normal 24 h following RA treatment. The mechanism of the down-regulation of 
goosecoid by RA was studied in P19 mause teratocarcinoma cells with reporter 
gene assay. A 4.8 kb goosecoid promoter-luciferase reporter gene was down-
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regulated by RA if RXR was co-transfected. Third, alteration of goosecoid 
epxression was investigated in RXRo:+/- and RXRo:-/- mouse embryos because 
RXRo:-/- mice were resistant to RA teratogenic effect on developing limbs compared 
with RXRo:+/+ and RXRo:+/- mouse embryos. 
Since goosecoid and BMP-4 antagonize each other in early gastrula frog 
embryo, and because of the role of BMP-4 in bone formation, alteration of BMP-4 
expression by RA was analysed in both E10.5 mouse embryos and F9 mouse 
teratocarcinoma cells. BMP-4 was down-regulated 4 h following tRA treatment of 
E10.5 mouse embryos. 24 h after tRA treatment BMP-4 expression was normal 
again. The mechanisms behind the down-regulation was studied in F9 cells with 
RAR and RXR specific ligands. The effect of RA on the expression of BMP-4 tagether 
with other three herneobox genes Msx1, Msx2 and hoxd-11 was also analysed in 
RXRo:+/- and RXRo:-/- mouse embryos. 
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2. Results 
2.1 Part I. The borneobox gene goosecoid: 
descriptive and functional analysis during 
mouse organogenesis 
ln order to unravel the role of goosecoid in murine organogenesis, the 
expression pattern of goosecoid was re-evaluated du ring mid embryogenesis. Two 
new goosecoid expression sites were identified in the developing trachea and 
external genitalia. ln addition, the expression pattern in the appendicular skeleton 
was studied in detail. goosecoid expression was found in the shoulder and hip joint 
region, and in several Iigaments and adductor muscles. ln collaboration with Gen 
Yamada (Kurume University, Japan), additional phenotypic abnormalities 
associated with this expression profile were found in goosecoid homozygous 
mutant mice (Zhu et al., 1998). 
2.1.1 Expression of goosecoid in the region of the 
developing Iarynx and trachea 
Fig. 1 shows the expression of goosecoid at E15.5 in the region of the Iarynx 
and the trachea by radioactive in situ hybridization. A clear signal was found 
araund the thyroid, cricoid and tracheal cartilages. goosecoid mRNA was confined 
to the mesenchyme surrounding the condensing cartilages, and the signal was 
notably strenger on the ventral side. The Iarynx and the trachea are derived from 
the hypobranchial groove, i.e. the inner branchial arch grooves. ln human embryos, 
the laryngeal cartilages are derived from the fourth and sixth branchial arch 
mesoderm (Mclachlan, 1994}. Expression of goosecoid at E10.5 to E12.5 is 
confined to arch I and II (Gaunt et al., 1993). ln the mause arch IV is very small, and 
arch VI cannot be distinguished. lt is therefore not clear if the pattern at E 15.5, 
depicted in Fig. 1, represents a continuation of an earlier expression of goosecoid, 
as is the case for arch I and II derived structures such as the tongue, mandible and 
mallaus (Gaunt et al., 1993). 
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Fig. 1. goosecoid is expressed in the area of the developing thyroid, cricoid, 
and tracheal cartilage. Sagittal section of a E1 0.5 mouse embryo. A, brightfield; B, darkfield. c: 
cricoid cartilage; h: hyoid cartilage; t: tongue; tc: thyroid cartilage; tr: tracheal cartilage. 
2.1.2 The submucosal layer of the tunica mucosa is 
deleted in the trachea of goosecoid mutant mice 
ln order to investigate if a Iack of goosecoid expression in the developing 
Iarynx and trachea in knockout mice resulted in developmental defects of these 
structures, I performed a skeletal analysis of tracheal cartilage from both wild-type 
and goosecoid null mutant mause embryos. Genotyped newborn mice were stained 
with alcian blue and alizarin red in order to visualize bone and cartilage, 
respectively, and stained tracheae were dissected. The trachea, from Iarynx to 
branchi, was analysed for developmental defects in goosecoid null mutant 
embryos. The trachea consists of a framewerk of incomplete rings of hyaline 
cartilage. As shown in Fig. 2, the thyroid, cricoid and trachea cartilages from 
goosecoid null mutant E 17.5 mause embryos (Fig. 2 8) were present, and they 
displayed normal morphology of tracheal cartilage rings compared with wildtype 
embryos (Fig. 2 A). The bifurcation of trachea cartilage seen in the mutant cartilage 
(Fig. 2 8) could also be observed in some wild-type tracheae (not shown), and can 
therefore not be attributed to the goosecoid mutation. A notable difference between 
the tracheal cartilages of wildtype and goosecoid null mutant mice was that tracheal 
cartilages from goosecoid null mutant mice were thinner than those of wild-type 
embryos (Fig. 2). 
Histologie analysis of tracheae was carried out in collaboration with Gen 
Yamada. The normal tracheal cartilages are united by fibrous tissue and smooth 
muscle, and lined by mucosa on the Iumina! side. The tunica mucosa, which is 
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continuous with the Iarynx above and the interpulmonary bronci below, is a layer of 
pseudostratified columnar epithelium interspersed with goblet cells (Fig. 3). 
Longitudinal elastic fibres separate the epithelium from the underlying submucosa 
of loose connective tissue, containing blood vessels, nerves, lymphoid nodules and 
the tracheal seromucous glands. External to the submucosa are the perichondrium 
and cartilage (Williams, 1995). ln goosecoid null mutant tracheae, the submucous 
layer was not present (Zhu et al., 1998). The epithelium, which was thinner than the 
epithilium of wild-type embryos, was directly bordering the hyaline cartilage. Since 
goosecoid was not expressed at the site of the developing submucosa during 
organogenesis, the absence of this layer in mutant mice should represent a non-
eeil autonomous effect of goosecoid gene function (s. Discussion). 
Fig. 2. Thyroid, cricoid, and tracheal cartilages of wild-type and goosecoid 
mutant mouse embryos. A: cartilage from wild-type E17.5 mouse embryo; 8: cartilage from E17.5 
goosecoid null mutant mouse embryo. th: thyroid cartilage; c: cricoid cartilage; tr: tracheal cartilage. 
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Fig. 3. Normal structure of trachea from wild-type new-born mouse (transverse 
section). e: ciliated columnar epithelium of tunica mucosa; oe: oesophagus; sml: submucous layer of 
tunia mucosa; tc: tracheal cartilage; th: thyroid gland. 
2.1.3 Expression of goosecoid in the shoulder and hip joint 
and in the appendicular skeleton 
ln the initial report of the goosecoid null mutant mouse, no phenotype related 
to the expression in the proximal limb bud at E10.5 and E12.5 was described 
(Yamada et al., 1995; Rivera-Perez et al., 1995). ln order to be able to analyze the 
mutant more specifically I re-investigated the expression pattern of goosecoid in 
wild type mouse ernbryos from E13.5 to E15.5. Fig. 4 A, B shows expression at 
E13.5 in the shoulder jointandin the Iigament attached to the humerus (asteriks in 
panel A). At Ei 4.5 goosecoid was expressed in the hip joint region between the 
head of the femur and the cup-shaped acetabulum of the innominate bone (Fig. 4 
C, 0), as weil as in the perichondrium surrounding the cartilage primordia of the 
iliac bone (Fig. 4 C, 0), pubic bone and- less pronounced - the ischial bone (Fig. 4 
E, F). goosecoid mRNA was abundant in Iigaments attached to the femur (asteriks 
in Fig. 4 E, F) andin a forming adductor muscle initiating at the pubic bone (Fig. 4 E, 
F). Within the developing hindlimb, goosecoid was expressed in the perichondrium 
and mesenchyme surrounding the tibia and fibula at E 13.5 and E 14.5 (Fig. 4 E-H). 
The diserste expression sites in the pelvic region are most likely the continuation 
and segregation of the early expression of goosecoid in the proximal limb bud. The 
expression pattern of goosecoid in those Iigaments and adductor muscles suggests 
that goosecoid may play a role in the patterning and formation of those tissues. 
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Fig. 4. Expression pattern of goosecold in the appendicular skeleton and 
Iabiaserotai folds at E13.5·E15.5. A-D: goosecoid is expressed in the shoulder joint and hip 
joint region. A, B: E13.5, sagital seetion of shoulder joint, nasaland middle ear region. C, D: E14.5, 
transverse seetion through the developing hip joint and iliae bone. E, F: Expression of goosecoid 
surrounding the developing isehial and pubie bone, and in the Iabiaserotai swellings at E 14.5 
(transverse seetion). G, H: Expression of goosecoid in the hind limb at E13.5 (transverse seetion). I, 
J: Expression of goosecoid in the mesenehyme of the Iabiaserotai swellings at E15.5 (sagital seetion). 
A, C, E, G, 1: bright field; B, D, F, H, J: dark field. af: aeetabular fossa; am: adduetor musele; bw: body 
wall; f: femur; fi: fibula; gt: genital tuberele; h: humerus; hj: hip joint; il: iliae bone; is: isehial bone; ls: 
Iabiaserotai swellings; m: malleus; ma: mandible; Me: Meekel's eartilage; nm: nasal mesenehyme; p: 
pubie bone; s: seapula; sj: shoulder joint; t: tibia; vr: ventral rib. The asterisks in 'A', 'E' and 'F' indieate 
ligments initiating at the humerus and femur. Small arrowheads in 'A' mark sites of goosecoid 
expression in the upper and lower lip. 
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2.1.4 
Results 
Malformation of innominate bone and hip joint in 
goosecoid mutant mice 
Newborn wild-type and goosecoid mutant animals were analyzed for 
abnormalities in the pelvic region by skeletal analysis and histological serial 
sections (Zhu et al., 1998). Bone and cartilage staining did not reveal gross 
alterations of the hip joint, while a dramatic hyperproliferation of the cartilage of the 
ischial bone was apparent in the mutants when compared to wild-type littermates. 
The ischial bone was significantly shortened in the mutant, and the pubic and iliac 
bone showed slight reductions in size as weil. While the phentype of the ischial 
bone dearly represents a specific result of the goosecoid mutation, the effect on 
pubic and iliac bone may be a consequence of the previsously noted general 
re•:' 'r:+ir)t"' in size of mutant mice. The pubic symphysis formed normally in mutant 
animals. 
Fig. 5. Histologie transverse section of normal structure of hip joint from wild-
type newborn mouse. af: acetabular fossa; f: femur; fo: fovea capitis femoris; h: head of the femur; 
1: Iigament of the head of the femur. 
Malformation of the hip joint became apparent in histological sections of 
newborn mutant mice (Zhu et al., 1998). ln wild-type mice the Iigament of the head 
of the femur, a triangular flat band, is attached anterosuperiorly in the fovea capitis 
femoris, a pit on the femoral head (Fig. 5). 8oth the fovea and the Iigament were not 
detected in mutant animals (Zhu et al., 1998). This correlates with the expression of 
goosecoid in the space between acetabular fossa and femur at E14.5. Also in 
agreement with the expression pattern, an adductor muscle initiating at the os pubis 
was apparently underdeveloped in goosecoid null mice, as was an adductor 
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musele eonneeting with the isehial bone (Zhu et al., 1998). Thus, mutant animals 
displayed abberant development of struetures in the pelvie region and hip joint that 
express goosecoid during organogenesis stages. 
2.1.5 Expression of goosecoid in the Iabiaserotai folds 
A new site of goosecoid gene expression was deteeted at E14.5 in the 
Iabiaserotai swellings, whieh develop one on eaeh side at the base of the phallus 
(Fig. 4 E/F). At E15.5 a streng positive signal was deteeted in the mesenehyme of 
the Iabiaserotai folds, whieh at this stage have extended to and have fused in the 
midline (Fig. 4 1/J). ln males these folds give rise to the serotat sae, in females they 
beeome the Iabia major. lnterestingly, goosecoid expression sites in the Iabiaserotai 
mesenehyme are destined to give rise to the external and internal muscles 
underlying the epithilium of Iabiaserotai swellings. Between the two muscles a 
faseia is loeated whieh serves as the attaehing tissue for the gubernaeulum, a 
ligamentaus eord, whieh in both sexes is erueial for the proper deseent of the 
gonads. The superior end of this eord attaehes to the gonad and its expanded 
inferior end (the gubernaeular bulb) attaehes to the faseia between the developing 
external and internal oblique museles in the region of the Iabiaserotai swellings. ln 
human embryos, the gubernaeulum eondenses during the seventh week within the 
subserous faseia. Between the 7th and 12th weeks, the extrainguinal portians of the 
gubernaeula shorten and pull the testes down to the vieinity of the deep inguinal 
ring within the plane of the subserous faseia (Fig. 6). Like the male embryo, the 
female embryo develops a gubernaeulum extending intially from the inferior pole of 
the gonad to the subeutaneous faseia of the presumptive Iabiaserotai folds. ln the 
female, the gubernaculum does not shorten, but deforms, or regresses. 
Nevertheless, it eauses the ovaries to deseend during the third month and to be 
swept out into a peritoneal fold ealled the broad Iigament of the uterus (Larsen, 
1997). The expression pattern of goosecoid in the Iabiaserotai mesenehyme 
suggests a role for the proper development of the external and internal muselas and 
the intervening faseia. lt is tempting to examine if goosecoid null mutant miee 
display any abnomalities with respeet to the deseent of either testes or ovaries. 
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Fig. 6. Descent of the testes in human embryos. (A-C) Between the seventh week 
and birth, shortening of the gubernaculum testis causes the testes to descend from the 1Oth thoracic 
Ievei into the scrotum. The testes pass through the inguinal canal in the anterior abdominal wall. (D) 
After the eighth week, a peritoneal evagination called the processus vaginalis forms just anterior to the 
gubernaculum and pushes out sock-like extentions of the transversalis fascia, the internal oblique 
muscle, and the external oblique muscle, thus forming the inguinal canal. The inguinal canal extends 
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from the base of the everted transversalis fascia (the deep ring) to the base of the everted external 
oblique muscle (the superficial ring). After the processus vaginalis has evaginated into the scrotum, 
the gubernaculum shortens and simply pulls the gonads through the canal. The gonads always remain 
within the plane of the subserous fascia associated with the posterior wall of the processus vaginalis 
(from Larsen, 1997). 
2.1.6 Abnormal epithelial development of the labioscrotal 
swellings in goosecoid mutant mice 
A comparative histological analysis was performed for newborn wild-type 
and mutant animals. Transversal sections of newborn goosecoid null mutant mice 
revealed abberant epidermal structures in the midline where fusion of the 
Iabiaserotai folds had occured. ln normal animals, three layers can be 
distinguished in the epidermis of seroturn and Iabia, an outer stratum corneum, a 
thick middle layer, the stratum spinosum, and the innermost thin stratum 
germinativum, consisting mostly of a single celllayer. The scrotal epidermis of wild-
type male newborn animals appears smooth except for some regularly spaced 
indentations, the sulci cutis. The three layers show equal thickness along the 
circumference of the serotat sac. ln mutant mice, however, the middle stratum 
spinosum displayed a massive hyperproliferation, which was clearly visible in 
histological sections of male animals, but less pronounced in females. ln addition, 
deep sulci were found which were not observed in normal mice. As goosecoid 
expression in the forming Iabiaserotai swellings was confined to the mesenchyme, 
the observed malformations of the epidermal cell layers represent non-eeil 
autonomaus effects, as described above for the submucosal layer of the trachea 
(see discussion). lt remains tobe elucidated whether mutantserotat mesenchyme 
displays abnormalities as weil. 
Taken together, goosecoid gene was found to be expressed in the 
mesenchyme surrounding the thyroid, cricoid and tracheal cartilages, in the 
shoulder joint, hip joint, and adductor musdes connecting pubic and ischial bones, 
in the perichondrum tissue surrounding pubic and ischial bone as weil as the 
perichondrum surrounding tibia and fibia. Another notable expression site was 
found in the mesenchyme of the Iabiaserotai swellings. The phenotypes related to 
the expression profile in goosecoid null mutant mice were found in trachea and 
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pelvic region. The submucosal layer was missing, and the Iigament of the head of 
the femur in the hip joint was not formed. 
2. 2 Part II. The borneobox gene goosecoid: a 
mediator of retinoic acid teratogenic 
effects in mouse embryos 
goosecoid null mutant mice displayed rib defects and craniofacial 
abnormalities, including defects of the tongue, nose and mandible, a loss of the 
tympanic ring and malformation of the mallaus (Rivera-Perez et al., 1995; Yamada 
et al., 1995). These phenotypes resembled some of the taratagenie effects of RA. 
For example, in mause embryos that were treated in utero with RA at ES plus 5 to 7 
h, the middle ear bones did not develop or became malformed (Malle, 1997). lt was 
tempting to speculate that goosecoid might play a role in mediating some of the RA 
teratogenicity. Additionally, goosecoid was shown to become down-regulated in 
early Xenopus embryos (Cho et al., 1992) and mause gastrulae (Bium, 199S) 
following RA-treatment. Three sets of experiments were performed in order to 
investigate such a link. First, mause embryos were treated in utero with 20 mg/kg 
all-trans RA (tRA) at ES + 5 h, a treatment that was shown to result in malformation 
or loss of the tympanic ring ( 13-15), and goosecoid expression in both control 
embryo and RA-treated embryos was analysed at E1 0.5. Second, mause embryos 
were treated at E10.5 when goosecoid showed streng expression in nasal 
mesenchyme, branchial arches, ventral body wall and proximal limb bud in order to 
examine the immediate effect of RA on the expression of goosecoid at that stage. 
Third, the mechanism of down-regulation of goosecoid by RA was investigated in 
P19 teratocarcinoma cells. 
2.2.1 goosecoid gene expression in branchial arches at 
E1 0.5 was altered when mouse embryos were treated 
with RA at ES + 5 h 
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ln order to understand if goosecoid plays a role in mediating RA 
teratogenicity in the development of middle ear bones, mause embryos at EB + 5 h 
were treated with 20 mg/kg tRA, and the expression of goosecoid in control and 
tRA-treated embryos was analysed at E1 0.5. Fig. 7 shows goosecoid mRNA 
expression in E1 0.5 mouse embryos that were treated with either vehicle solution 
(10 % DMSO in sesame oil; Fig. 7A, A'), or 20 mg I kg tRA (Fig. 78, B' ,C, C'). 
Control treated embryos displayed the normal goosecoid expression pattern (Fig. 
7A') in the mesenchymal cells of branchial arch I and the anterior third of branchial 
arch II, as described by Gaunt et al. (1993). ln contrast, these hybridization signals 
were severely altered in RA-treated embryos. Two types of changes were 
observed. ln most cases goosecoid mRNA expression became restricted to cells in 
the branchial cleft between arch I and arch II, as shown for the embryo depicted in 
Fig. 1 B, B'. The second type of change was characterized by a reduction of 
goosecoid transcripts to background Ieveis in the branchial region of the embryo, 
as shown in Fig. 7C, C'. The change of goosecoid expression following RA-
treatment was specific for the branchial region. The expression pattern of 
goosecoid in the nasal mesenchyme, in the proximal limb buds and in the adjacent 
body wall was not affected by RA treatment at E8 + 5 h (Fig. 7 B', C' and data not 
shown). 
Fig. 7. Alteration of goosecoid gene expression following RA treatment of 
mouse embryos in vivo at E8 + 5 h. Mouse embryos were treated with 20 mg/kg tRA and 
analyzed at E10.5 for goosecoid gene expression by in situ hybridization of sectioned embryos. A/A : 
control treated embryo. 8/B' and C/C ': RA-treated embryos. Note that expression of goosecoid in 
branchial arches I (b1) and II (b2) of RA-treated embryos was either restricted to the branchial cleft 
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region (bc, 8'), or reduced to Ieveis close to background (C'), whereas the signal in the nasal 
mesenchyme (nm) was unaffected. h: heart; A/8/C: bright field; A'/8'/C': dark field. 
2.2.2 Malformation and loss of middle ear bones upon 
RA treatment of mouse embryos at ES + 5 h 
To analyze if and how this alteration of goosecoid gene expression was 
related to teratogenic effects of RA, embryos that were treated in utero in parallel 
under identical conditions were analyzed for skeletal defects at E17.5 by staining 
with dyes specific for bone (alizarin red} and cartilage (alcian blue). Fig. 8 shows 
the result of such an experiment. While treatment with vehicle solution did not affect 
the skeleton (Fig. 8 A}, RA-treated mouse embryos revealed severe alterations. ln 
all cases the cartilage primordia of the middle ear ossicles, malleus, incus and 
stapes, could not be detected. Cartilaginous condensations were sometimes 
present. According to their anatomical position relative to Meckel's cartilage and 
other bones in the otic region these cartilages should be hypoplastic forms of the 
middle ear bones, but they never showed the typical morphology of malleus, incus 
or stapes (see arrows in Fig. 8 8, C). The tympanic ring was either grossly reduced 
in size and malformed (Fig. 8 8), or absent (Fig. 8 C), although a remnant of a 
cartilaginous condensation could also indicate the position of the tympanic ring 
(arrow in Fig. 8 C). A complete loss of the tympanic ring was seen less frequently 
(<20 %) than a partial reduction to varying degrees. Other skeletal elements in the 
craniofacial region that were affected by RA-treatment included the gonial bone, 
squamosal bone and styloid cartilage (Fig. 8 8, C). 
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Fig. 8. Loss of tympanic ring and middle ear ossicles following RA treatment 
of mouse embryos in vivo. Mouse embryos were treated at EB + 5h with 20 mg/kg tRA and 
analysed at E17.5 for skeleton abnormalities by bone and cartilige staining. A: control embryo. B/C: 
RA-treated embryos. Note that RA-treatment resulted in either a partial (B) or complete loss of the 
tympanic ring (r), whereas the middle ear ossicles, malleus (m), incus (i) and stapes (s) were deleted, 
and styloid cartelage (sy), gonial bone (g) and squamosal bone (sq) were affected in all embryos 
analyzed. MC: Meckel's cartilage. Arrows in (B) and (C) indicate cartilaginous condensations 
reminiscent of middle ear ossicles and tympanic ring. 
2.2.3 Down-regulation of goosecoid 4 h after treatment of 
mouse embryos with RA at E1 0.5 
Treatment of rodent embryos from embryonie day 9.5 to 11.5 results in digit 
truncations and long bone reductions of limbs ( Kochhar, 1973, 1985; Tickle et al., 
1985) when RA is delivered to embryos through matemal treatment and reaches 
systemic rather than localized Ieveis throughout the limb buds. This malformation 
caused by systemic application of RA to the limb buds is different from localized 
application. ln centrast to the malformation of limb buds caused by localized 
application of RA (see introduction), the cause of malformations resulting from 
systemic RA application is not weil known. 
Since goosecoid is expressed in the proximal limb bud and in the limb 
mesenchyme surrounding radius and ulna (Fig. 4 H), and because misexpression 
of goosecoid in the chick limb bud caused malformation of limb long bones 
(Heanue et al., 1997), I analysed if and how goosecoid is involved in the RA 
taratoganie pathway in limb development. 
ln order to investigate if RA can regulate goosecoid expression at E1 0.5, 
mouse embryos at E1 0.5 were treated with 20 mg/kg all trans retinoic acid (tRA) for 
4 h. The dosage of tRA is a standard dosage that has been used by other 
investigators (Marshall et al., 1992). Control mice were treated with vehicle solution, 
namely 10% ethanol in sunflower oil. As shown in Fig. 9, E10.5 control embryo had 
normal goosecoid expression pattern in nasal pit, branchial arches and ventral 
body wall (Fig. 9 A, A'), while goosecoid expression was dramatically reduced 4 h 
after RA treatment (Fig. 9 B, B '). The repression of goosecoid by RA appears 
uniform at all gooseocoid expression sites in E1 0.5 mouse embryos, including the 
limb mesenchyme (Fig. 1 0 ) where teratogenic effects occur. ln order to know how 
long the repression of goosecoid expression lasts following a single treatment of 
mouse embryos with 20 mg/kg tRA, mouse embryos were isolated 24 h after a 
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single dose treatment with 20 mg/kg tRA at E10.5. As shown in Fig. 9 C, C', 
goosecoid was no Ionger repressed 24 hours after the treatment (Fig. 9 C, C '). 
Fig. 9 Transient repression of goosecoid in mause embryos by RA at E 1 0. 5. 
Embryos were treated with vehicle solution (A/A') or with 20 mg I kg tRA at E1 0.5 in vivo and analyzed 
for goosecoid gene expression after 4 h (8/8') or 24 h (C/C'). b1/b2: branchial arch I and II; bw: body 
wall; h: heart; nm: nasal mesenchyme. 
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Fig. 10. Down-regulation of goosecoid by RA in the developing limb bud 4 h 
after RA treatment. A: limb bud from a control E10.5 mouse embryo; B: limb bud from a E1 0.5 
mouse embryo treated with 20 mg/kg tRA. 
2.2.4 RA teratogenic effect following treatment of mause 
embryos at E10.5 
To show that RA treatment is effectively teratogenic to developing mause 
embryos, some Iittars of mause embryos treated maternally with a single dosage of 
20 mg/kg tRA at E1 0.5 were kept for further development until birth. All of the 
newborn mause embryos after tRA treatment at E1 0.5 died within 24 hours after 
birth. Ninety percent of newborn babies showed cleft palate and other 
developmental defects (data not shown). 
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Fig. 11. Teratogenic effect of RA on limb development at E 1 0. 5. Wild-type 
'"lb;yos were treated with control solution (A) and 3 times 20 mg/kg tRA (each time for 8 h) (8). 
1s prepared from E 17.5 control mouse embryo (A) and tRA-treated mouse embryo (8). 
!\lote tlie defects of humerus, radius , ulna and digit in tRA-treated forelimb (8). h: humerus; r: radius; s. 
scapula; u: ulna 
Besides a single dose treatment, mause embryos at E 10.5 were also treated 
with 20 mg/kg tRA for three times with an interval of 8 hours between each 
treatment. Mouse embryos were collected at E17.5 for skeleton analysis after tRA 
treatment. All of the tRA-treated embryos had lang bone defects in forelimbs 
including severe malformation of humerus, radius and ulna as dipicted in Fig. 1 i. 
Succesive low dosage tRA (20 mg/kg) treatment of mouse embryos induced 
forelimb long bone malformation in the same way as a single high dosage (1 00 
mg/kg). A single high dosage tRA treatment not only resulted in forelimb and 
hindlimb long bone defects but also caused severe truncations of the caudal 
vertebrae of developing mouse embryos (data not shown). ln contrast, succesive 
low dosage treatment did not cause severe teratogenic effect on the development of 
mouse hind limbs and caudal vertebrae. 
2.2.5 Mechanism of down-regulation of goosecoid by RA 
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The rapid and transient down-regulation of goosecoid by RA suggests that 
the RA effect may be mediated by its receptors, and that down-regulation of 
goosecoid may occur at the transcriptional Ievei. 
To test if the down-regulation of gossecoid by RA was mediated through the 
goosecoid promoter, a 4.8 kb fragmant of the mouse goosecoid promoter was 
cloned into the luciferase reporter vector PXP2 (Fig. 12). 
TATA r: ATG 
4.8 kb mouse goosecoid promoter 
TATA r: ArG 1: ~: ~: )Qcirf:erase.: ~: ~: ~: ~: ~: 1 
·.·.·.·.·.·.·.·.·.·.·.·.·.·.·.· 
reporter gene construct 
cotransfection into P19 cells 
(with or without RXR) 
t 14 h 
+ Iigand ( 1 JJM) 
+ 24 h 
determination of luciferase activity in cell extracts 
Fig.12. Diagram of goosecoid promoter-luciferase reporter construct and 
DNA transfection procedure. 
The 4.8 kb goosecoid promoter-luciferase reporter was transfected into P 19 
mouse embryonie teratocarcinoma cells because this reporter gene was shown to 
be active in P19 cells (Danilov et al., 1998; Fig. 13). Treatment of the reporter gene-
transfected P19 cells with 1 J..LM tRA or 1 J..LM 9-cis retinoic acid (9-cis RA) for 24 
hours did not result in repression of the luciferase activity of the reporter gene. RA 
signaling is transduced by AARs and RXRs receptors. ln P19 cells, both RAR and 
RXR are expressed but at a low Ievei (Durand et al., 1992). RARß can be up-
regulated by RA (Bhattacharyya et al., 1997) wherease RXR isoforms can not. I 
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reasoned that RXR may be a limiting factor for mediating RA signaling in P19 cells. 
Therefore, in the following experiments, a RXRa expression vector (Chambon, 
1994) was cotransfected with the reporter gene. Fig. 13 shows that the reporter 
gene could be down-regulated 2 fold by 1 f.!M tRA or 3 to 4 fold by 1 f.!M 9-cis RA 
when a RXRa expression vector was cotransfected (Fig. 13). 9-cis RA was more 
potent in the down-regulation of goosecoid promoter activity than tRA under the 
same conditions. 
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Fig. 13. Down-regulation of goosecoid promoter-luciferase reporter in P 1 9 
cells by RA. P19 cells were transfected with a 4.8 kb mouse goosecoid promoter-luciferase reporter 
gene either with (+RXRa) or without (-RXRa) cotransfection of RXRa. After washing of the DNA 
precipitates, cells were treated with control solution, 1 f.l.M tRA or 1 f.l.M 9-cis RA for 24 hours. 
ln order to investigate which RXR isoform was able to mediate RArepression 
of goosecoid, RXRß and RXRy were included in the study as weil. Fig. 14 shows the 
result from the experiments. RXRa, RXRß and RXRy were able to mediate the 
repression of the goosecoid reporter gene. However, RXRa was found to be the 
most potent in mediating the down-regulation of the reporter gene, followed by 
RXRß and RXRy (Fig. 14). 
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Fig. 14. RXRa is more potent in mediating the down-regulation of the 
goosecoid reporter gene than RXRß and RXRy. P19 cells were transfected with 4.8 kb mouse 
goosecoid promoter-luciferase reporter and RXRa, RXRß or RXRy .. 
AmBO is a selective Iigand for RARa because it can bind RARa specifically 
and transactivate a reporter gene through RAR and RXR heterodimer (Delescluse et 
al., 1991 ). SR11237 is an RXR specific Iigand. lt can only activate RXR homodimer 
but not RAR and RXR heterodimers (Xiao et al., 1995). To distinguish the RAR and 
RXR retinoid signaling pathway, the RARa specific Iigand AmBO and the RXR 
specific Iigand SR11237 were used in this study. P19 cells were co-transfected with 
the goosecoid reporter gene and the RXRa expression vector (Fig. 12). After 
transfection cells were treated with 1 ~M AmBO or 1 ~M SR 11237, respectively, for 
24 h. Fig. 15 shows that both the RARa specific Iigand AmBO and RXR specific 
ligands were able to repress the luciferase activity of the goosecoid reporter gene. 
However, the RXR-specific Iigand SR11237 was more potent than AmBO in down-
regulation of the reporter gene. ln order to analyse if there is any synergistic effect of 
AmBO and SR11237 in down-regulation of goosecoid reporter gene, both ligands 
were added to the reporter gene transfected P19 cells simultaneously. As shown in 
Fig.15, no synergistic effect of RAR and RXR specific ligands was observed. 
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However, the result implicates both RAR and RXR in the down-regulation of 
goosecoid pomoter activity. 
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Fig. 15. Repression of goosecoid reporter gene by RAR or RXR specific 
ligands. P19 cells were transfected with 4.8 kb mouse goosecoid promoter-luciferase reporter gene 
together with RXRa. Transfeeted cells were treated with 1 J.!M RAR-specific Iigand AmBO or 1 JlM RXR-
specific Iigand SR11237, or both. 
RXRs along with other members of the nuclear hormone receptor superfamily 
have a highly conserved ONA binding domain (080), a Iigand-binding domain 
(L80), as weil as a less conserved amino-terminal domain and a hinge region 
present between the 080 and L80 (Mangelsdorl et al., 1995; 8eato et al., 1995). 
The schematic structure of RXRa is shown in Fig. 16 A. The L80 not only binds to a 
specific Iigand but is also involved in dimerization with other receptors. The L8D 
also contains a ligand-dependent transcriplienal activation domain called AF-2 to 
distinguish it from the less weil characterized amino-terminal domain AF-1, present 
in many receptors (Mangelsdorl et al., 1995; 8eato et al., 1995). To investigate 
which domain of RXR is required for the repression of the reporter gene, a dominant 
negative RXRa that Iacks the AF-2 transactivation domain (Feng et al., 1997) was 
cotransfected with the reporter gene in P19 cells. Fig. 16 8 shows that the dominant 
negative RXRa could not mediate the repression of the reporter gene by either tRA 
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or 9-cis RA. This result indicates that the AF-2 transactivation domain of RXRa is 
implicated in the repression of the reporter gene. 
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Fig. 16. Dominant negative RXRa abolishes the repression of goosecoid 
reporter by RA. A. Schematic structure of RXR. B. P19 cells were transfected with 4.8 kb mause 
goosecoid promoter-luciferase reporter gene with a dominat negative RXRa that Iacks AF2 
transactivation domain. Cells were treated with 1 ~M 9-cis RA for 24 hours. 
ln summary, in part two I showed that first, goosecoid expression in branchial 
arches was specifically altered following tRA treatment of E8 + 5 h mouse embryos, 
and the alteration of goosecoid expression in branchial arches correlates with the 
loss or malformation of middle ear bones; second, goosecoid was repressed by tRA 
in E 10.5 mouse embryos 4 h after tRA treatment; third, down-regulation of a 4.8 kb 
mouse goosecoid promoter-luciferase reporter by tRA was RXR dependent. AF-2 
domain of RXR was indispensible for the down-regulation of the reporter gene. 9-cis 
RA is more potent in the down-regulation of the reporter gene than tRA. RXRa is 
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the most potent RXR isoform in mediating the repression of the reporter gene 
followed by RXRß and then RXRy. 
2. 3 Part 111. Down-regulation of BMP-4 by RA in 
mouse embryos and in F9 
teratocarcinoma cells 
The expression pattern of BMP-4 during Xenopus gastrulation revealed a 
transcript distribution which is complementary to that of genes transcribed in the 
Spemann organizer, such as goosecoid. Ectopic expression of goosecoid in 
Xenopus marginal zone led to repression of BMP-4 expression (Fainsod et al., 
1994). On the other hand, in mouse embryogenesis, the expression of goosecoid 
and BMP-4 at all developmental stages is also mutually exclusive. This suggests a 
similar genetic interaction between them as found in early Xenopus gastrula 
embryos. A simple hypothesis would be that as an antagonizing molecule of 
goosecoid, BMP-4 would be up-regulated when goosecoid was down-regulated 
following RA treatment of mouse embryos. 
To test if down-regulation of goosecoid by RA in mouse embryos would Iead 
to up-regulation of BMP-4, and what is the effect of RA on BMP-4 expression in 
mouse embryos, the following experiments were performed. 
2.3.1 goosecoid represses BMP-4 promoter activity in F9 
cells 
The homeodomain protein goosecoid can act as transcriptional repressor 
(Danilov et al., 1998). lt can bind TAAT and ATTA DNA sequence motifs and 
negatively regulate transcription. As a transcription factor with repressor property, 
goosecoid may regulate BMP-4 directly at the transcriptional Ievei. ln order to test 
this assumption, a 1.5 kb BMP-4 promoter fragment was cloned from mouse 
genomic DNA by PCR. After examination of the promoter, several TAAT and ATTA 
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sequences were found in the promoter (Fig.17 A). To analyse the regulation of the 
8MP-4 promoter by goosecoid, the 1.5 kb 8MP-4 promoter fragment was cloned 
into the PGL2 vector which has an SV40 minimal promoter in front of the luciferase 
reporter gene. The resulting heterologous 8MP-4 promoter-luciferase reporter gene 
(8r) was transfected into F9 mause embryonie teratocarcinoma cells. As shown in 
Fig. 178, the reporter gene is active in F9 cells. A goosecoid expression vector was 
used as decribed by Danilov et al. (1998) in which the goosecoid cDNA is driven by 
the CMV promoter. Co-transfection of the goosecoid expression vector tagether 
with the 8MP-4 promoter-luciferase reporter construct resulted in 4 to 5 fold 
repression of the luciferase activity of the reporter gene (Fig. 178). This result 
suggests that 1.5 kb of the 8MP-4 promoter is able to mediate the repression of 
8MP-4 by goosecoid. 
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Fig. 17. Down-regulation of BMP-4 promoter activity by goosecoid in F 9 
cells. A: putative homeodomain binding sites in the BMP-4 promoter (TAAT and ATTA,boxed). 8: 
Down-regulation of BMP-4 promoter-luciferase reporter activity (Br) by goosecoid (gsc). 
2.3.2 Down-regulation of BMP-4 by RA in mouse embryos 
ln order to test if down-regulation of goosecoid by RA would Iead to up-
regulation of BMP-4 because of the antagonism between the two genes found in 
early trog embryos, E1 0.5 mouse embryos were treated with either vehicle control 
solution or 20 mg/kg tRA by oral gavage. Mouse embryos were isolated 4 h and 24 
h after tRA treatment respectively. Radioactive in situ hybridization was performed 
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on sagital sections from both control and tRA-treated E10.5 mouse embryos. Fig. 18 
A, A' shows the normal 8MP-4 expression in the epithilium of branchial arches, 
heart and in the apical setodermal ridge (AER) of the limb bud at E1 0.5. This normal 
expression was down-regulated 4 hours after treatment of embryos with tRA (Fig. 18 
8, 8'). ln order to test the duration of the down-regulation of 8MP-4 by RA, mouse 
embryos were isolated 24 hours after RA treatment. The expression of 8MP-4 was 
analysed in these embryos as weil. Fig. 18 C, C' shows that the expression pattern 
of 8MP-4 was normal again at all expression sites 24 hours after RA treatment of 
mouse embryos at E10.5. This result showed that down-regulation of goosecoid by 
RA did not result in up-regulation of 8MP-4. On the contrary, BMP-4 was rapidly 
repressed by RA treatment. 
Fig. 18. Transient repression of BMP-4 by tRA at E10.5 mouse embryos. 
Embryos were treated with vehicle solution (AIA') or with 20 mg I kg tRA at E1 0.5 in vivo and analyzed 
for BMP-4 gene expression after 4 h (8/8') and 24 h (C/C'). A, 8, C: bright field; A', 8', C': dark field. b1: 
branchial arch I; bw: body wall; h: heart; 1: limb bud. 
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2.3.3 
Results 
Mechanisms of the RA-mediated down-regulation of 
BMP-4 
Mouse embryos in utero are not suitable for well-defined study of the 
mechanisms for the regulation of certain endogenaus genes by ligands. This is 
because the amount of the Iigand that an embryo receives can not be controlled 
very weil. An alternative way to study the regulation of genes by hormones or by 
other ligands is to turn to cell lines. F9 mause teratocarcinoma cells are suitable for 
the study of the regulation of BMP-4 by RA because BMP-4 is expressed 
endogenousely in F9 cells (Rogers et al., 1992) and RAR and RXR are expressed in 
this cellline as weil (Aneskievich et al., 1992). 
BMP-4 
GAPDH 
Fig. 19. Down-regulation of BMP-4 24 h after treatment of F9 cells with RA. F9 
cells were treated with different ligands for 24 hours. Total RNA was isolated from each treatment. 20 
J.lQ of total RNA from each sample was seperated on a 1% agarose formaldehyde gel. The RNA was 
transfered to a nylon mebrane. After cross-linking, the membrane was probed with 32P-Iabeled BMP-4 
and GAPDH probe successively. 
ln order to study if BMP-4 can be down-regulated in F9 cells by RA and which 
receptor is involved in the repression of BMP-4, F9 cells were treated with tRA ( 1 
~M), 9-cis RA (1 ~M), RAR-specific Iigand AmBO (1 ~M) or RXR-specific Iigand 
SR11237 (1 ~M) for 24 hours. Total RNA was isolated and analysed on a Northern 
blot. The blot was hybridized successively with 32P-Iabeled BMP-4 and 
glyceraldehyd 3-phosphate dehydrogenase (GAPDH) probes, respectively. 
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GAPDH, as a houskeeping gene serves as loading control. As shown in Fig. 19, 
BMP-4 was expressed in this experiment in F9 cells. The expression was down-
regulated by tRA, 9-cis RA, and by the RAR-specific Iigand Am80 24 h after 
treatment of the cells with these ligands. The RXR-specific Iigand SR11237, 
however, could not repress BMP-4 expression in F9 cells as efficiently as the other 
ligands. Taken together, the data indicates that repression of BMP-4 by RA is mainly 
mediated by RAR. However, participation of RXR can not be excluded because RXR 
could be a silent partner for RAR (Xiao et al., 1995). RXR homodimers may not be 
implicated in the repression of BMP-4 by RA. lnduction of one additional transcript 
might be due to activation of RXR homodimers by the RXR-specific Iigand SR11237. 
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BMP-4 
18S RNA 
1 OOng/ml TP A 
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Fig. 20. The expression of BMP-4 is not up-regulated by TPA treatment in F 9 
cells. A: AP-1 like sites in the BMP-4 promoter. B: F9 cells were treated with different combinations of 
TPA (100 ng/ml), tRA (111M) and 9-cis RA (1 j.tM) for 4 h. Total RNA was isolated, and 20 119 total RNA 
from each sample was analysed by Northern blot with a BMP-4 probe. 188 RNA serves as loading 
control. 
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Down-regulation of genes by RA could be due to cross-talk between RAR or 
RXR and AP-1 transcription factors (Nicholson et al., 1990; Schüle et al., 1991; 
Yang-yen et al., 1991; Salbartet al., 1993). There are two AP-1 like sites in BMP-4 
promoter (Fig. 20 A). These AP-1 like sites suggest putative positive regulation of 
BMP-4 expression by AP-1, and indicate the possibility that RA-mediating down-
regulation of BMP-4 occurs through this mechanism. Several studies indicate, 
however, that F9 cells Iack AP-1 activity (van Dam et al., 1995; Diccianni et al., 
1992). F9 cells do not express c-jun (van Dam et al., 1995), and nuclear extract 
proteins from F9 cells do not bind to AP1 response elements (Diccianni et al., 
1992). 
ln order to prove that BMP-4 expression in F9 cells is independent of AP-1 
transcription factors, F9 cells were treated with or without 1 00 ng/ml tumor promoter 
12-0-tetradecanoyl phobol-13-acetate (TPA) and in a combination with tRA and 9-
cis RA for 4 hours, a treatment which stimulates AP1 activity in many cell lines. Total 
RNA was isolated for Northern blot analysis. The blot was hybridized with a 32P-
Iabeled BMP-4 probe. 18s ribosemal RNA was used as a loading control. As shown 
in Fig. 20 B, treatment of F9 cells with 100 ng/ml TPA did not up-regulate BMP-4 
gene expression. This suggests that AP-1 is not implicated in the activation of BMP-
4 expression in F9 cells. Therefore, down-regulation of BMP-4 by RA can not be 
mediated by antagonizing AP-1 activity. 
BMP-4 
GAPDH 
201Jg/ml CHX 
11JM 9-cis RA 
+ 
+ 
+ 
+ 
Fig. 21. Down-regualtion of BMP-4 by 9-cis RA in F9 cells does not require 
new protein synthesis. F9 cells were treated without (control) or with 20 IJ.Q/ml cychloheximide 
(CHX) for 30 min before addition of 9-cis RA and cultured for an additional 4 h. 20 119 total RNA from 
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each sample was used for a Northern blot. The blot was hybridized successively with 32P-Iabeld BMP-4 
and GAPDH probes. 
To test if down-regulation of BMP-4 by RA treatment is due to up-regulation of 
a repressor or down-regulation of an activator for BMP-4 transcription, F9 cells were 
treated with 9-cis RA in combination with the inhibitor of protein synthesis, 
cycloheximide (20 jlg/ml) in order to inhibit de novo protein synthesis. After 
treatment of F9 cells with different reagents as shown in Fig. 21, total RNA was 
isolated from control and 9-cis RA treated F9 cells for Northern blot analysis. The 
blot was hybridized with 32P-Iabeled BMP-4 and GAPDH probes successively. ln 
Fig. 21 loading of total RNA was not equal for each lane as shown by GAPDH 
signal, so it was necessary to normalize the signal of BMP-4 by GAPDH. After 
normalization, BMP-4 was shown tobe repressed 4 hours after treatment with 9-cis 
RA, and cycloheximide did not inhibite the repression of BMP-4 by RA. 
2.3.4 Effect of RA treatment on goosecoid and BM P-4 
expression in RXRa-/- mice 
Mutations of two alleles of the RXRa gene resulted in mouse embryonie 
lethality around E 15.5 due to cardiomyocyte hypoplasia (Sucov et al., 1994; 
Kastner et al., 1994). lnterestingly, RXRa null mutant mice were resistant to the 
teratogenic effects of RA in limb development compared with wild type and 
heterozygous mutant embryos (Sucov et al., 1995). RXRa mutant embryos are 
therefore good tools for analysing the mechanism of RA teratogenesis on limb 
development. 
8oth goosecoid and BMP-4 are expressed in the developing mouse limb 
bud. They have different roles for normal limb development. BMP-4 is expressed in 
the AER of developing limbs and in limb mesenchyme (Fig. 18 A' and C'). 
Heterozygous BMP-4 mice showed digit defects (Dunn et al., 1997). BMP-4 plays a 
role in chondrogenesis of developing mouse limbs as weil since application of 
BMP-4 protein to developing chick limb buds induced ectopic bone formation. lt was 
therefore interesting to investigate if down-regulation of goosecoid and BMP-4 by 
RA in limb buds is RXRo: dependent, and if goosecoid and BMP-4 are involved in 
RXRo:-mediated RA teratogenesis pathway in developing limbs. 
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Three additional homeobox genes Msx1, Msx2 and Hoxd-11 were included 
in this study because of their known role in limb development. Hoxd-11 is a 
regulator of limb development (Davis et al., 1994). Double knock-out of Hoxd-11 
and Hoxa-11 in mice revealed that both genes are required for the normal 
development of radius and ulna (Davis et al., 1995) in forelimb. This phenotype is 
reminiscent of RA teratogenic effect on radius and ulna development. 
RXRa+/- male and female mice were mated in order to analyse the effect of 
RA on the expression of goosecoid, BMP-4, Msx1, Msx2 and Hoxd-11. Embryos 
were treated at E10.5 with either vehicle solution (10% ethanol in sunflower oil) or 
20 mg/kg tRA for 4 hours. Embryos were genotyped by PCR of genomic DNA 
isolated from the yolk sac tissue of each embryo. Fig. 22 shows the DNA fragments 
of the genotypes of RXRa+/- and RXRa-/-embryos. 
RXRa +1- RXRa -/-
300 bp 
250 bp 
Fig. 22. Genotyping of RXRa+/- and RXRa-1- mouse embryos. Genomic DNA was 
isolated from embryonie yolk sac tissue. PCR was performed to distinguish the genotypes of RXRo: 
null mutant embryos and RXRo: heterozygous embryos. The 300bp fragment represents the mutant 
allele, and a 250 bp amplification fragment is indicative of the wildtype gene. 
Radioactive in situ hybridization was performed with the o:35S-Iabeled probes 
for goosecoid, BMP-4, Msx1, Msx2 and Hoxd-11 on sagittal sections from both 
control E10.5 mouse embryos and tRA-treated E10.5 mouse embryos with RXRo: +l-
and RXRo: -/- genetic background, respectively (Fig. 23 and Fig. 24). 
As shown in Fig. 23, goosecoid was normally expressed in the nasal 
mesenchyme, first and second branchial arches, and the intervening branchial arch 
cleft, and in the proximal limb bud in E1 0.5 RXRo:+/- control emryos (Fig. 23 A, A'). 
This expression profile was repressed by tRA within 4 h following tRA treatment of 
mouse embryos (Fig. 23 B, 8'). goosecoid expression in RXRo:-/- null mutant mice 
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appeared normal (Fig. 24 A, A'}, but it was also repressed in RXRa-/- null mutant 
mice (Fig. 24 B, B'}. 
BMP-4 was expressed in the epithelium of the maxillary, the epithelium of the 
first branchial arch and in the atrium of heart of contol E1 0.5 RXRa+/- mouse 
embryos (Fig. 23 C, C'}. At all sites the expression was down-regulated by tRA in 
RXRa+/- embryos (Fig. D, D'}. Although RXRa-/- mutant embryos had heart defects, 
BMP-4 transcripts were still present in the atrium of the E1 0.5 heart (Fig. 24 C, C'}. 
Msx1 was expressed in the upper facial process, the first, second and third 
branchial arches, andin limb buds in control E10.5 RXRa+/- embryos (Fig.23 E, E'}. 
The expression of Msx1 was repressed in RA-treated E1 0.5 RXRa+/- mouse 
embryos (Fig. 23 F, F'}. ln RXRa-/- mutant mouse embryos, Msx1 was normally 
expressed (Fig. 24 C, C'}, as in RXRa+/- embryos. The normal expression pattern of 
Msx1 was down-regulated by tRA in E10.5 RXRa-/- mutant embryos (Fig. 24 F, F'}. 
Msx2 was normally expressed in the upper facial process, in the anterior of 
the first branchial arch andin the otic vesicle of RXRa+/- E10.5 control embryos (Fig, 
23 G, G'}. Only very faint signal of Msx2 is visible in tRA-treated E1 0.5 RXRa+/-
embryos (Fig. 23 H, H'}. The normal expression of Msx2 in tRA-treated E1 0.5 
RXRa+/- embryos was down-regulated 4 hours following tRA treatment of mouse 
embryos (Fig. 23 H, H'}. ln E1 0.5 RXRa-/- mutant embryos Msx2 was normally 
expressed (Fig. 24 G, G'). Following RA treatment of E10.5 RXRa-/- mutant embryos 
for 4 h, there was still strong Msx2 expression signal in maxillary (Fig. 24 H, H'). ln 
cantrast to the eftect of RA on Msx2 expression in RXRa+/- embryos, Msx2 was not 
repressed by RA treatment in E 1 0.5 RXRa-/- mutant embryos. 
Hoxd-11 was expressed in the distal limb bud of control E10.5 RXRa+/-
mouse embryo (Fig. 23 I, I'}. lt was repressed by tRA in treated E1 0.5 RXRa+/-
mouse embryos (Fig. 23 J, J'}. The normal expression of Hoxd-11 in RXRa-/-
mouse embryoswas down-regulated as weil (Fig. 24 I, I', J and J'}. 
Part 111 showed that BMP-4 was down-regulated following RA treatment in 
both mouse embryos and in F9 cells. ln mouse embryos, BMP-4 was repressed 4 h 
after RA treatment. ln F9 cells tRA, 9-cis RA and RAR-specific Iigand efficiently 
repressed BMP-4 expression. Remarkably RXR-specific Iigand could not repress 
BMP-4 expression. Down-regulation of BMP-4 by RA did not require new protein 
synthesis. 
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-RA +RA 
RXRa +1-
Fig. 23. Down-regulation of genes by RA in RXRa+/- mouse embryos. 
Radioacitive in situ hybridization was carried out on sagital sections of RXRa+/- E1 0.5 mouse embryos 
with probes for goosecoid (A/A', 8/8'), 8MP-4 (C/C', 0/0'), Msx1 (E/E', F/F'), Msx2 (GIG', H/H'), and 
Hoxd-11 (1/1', J/J'). Sections of A/A', C/C', E/E', GIG' and 111' were from control embryos treated with 
vehicle solution. Sections of 8/8', 0/0', F/F', H/H' and J/J' were from 20 mg/kg tRA-treated embryos. 
m: maxillary; n: nasal mesenchyme; b1: branchial arch 1; b2 branchial arch 2; h: heart; 1: limb bud. 
ln RXRa +1- mouse embryos goosecoid and BMP-4 together with Msx1, Msx2 
and Hoxd-11 were repressed by RA. However, in RXRa-/- mouse embryos Msx2 
expression was not repressed by RA, and the repression of BMP-4 by RA was far 
less pronounced in RXRa-/- mouse embryos than in RXRa +1- mouse embryos. ln 
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RXRa-/- mause embryos goosecoid, Msx1 and Hoxd-11 were still down-regulated 
following RA treatment. 
-RA +RA 
RXRa -/-
Fig. 24. Down-regulation of genes by RA in RXRa-/- genetic background. 
Radioacitive in situ hybridization was carried out on sagital sections of RXRa-/- E10.5 mouse embryos 
with probes of goosecoid (A/A', 8/8'), 8MP-4 (C/C', D/D'), Msx1 (E/E', F/F'), Msx2 (GIG', H/H'), and 
Hoxd-11 (1/1', J/J'). Sections of A/A', C/C', E/E', GIG' and 111' were from control embryos treated with 
vehicle solution. Sections of 8/8', D/D', F/F', HIH' and J/J' were from 20 mg/kg tRA-treated embryos. 
m: maxillary; n: nasal mesenchyme; b1: branchial arch 1; b2 branchial arch 2; h: heart; 1: limb bud 
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3. Discussion 
This study provides an in-depth analysis of goosecoid expression at mid-
embryogenesis in the mouse. Phenotypes corresponding to the newly described 
expresion in 'trachea and pelvic region are described. ln addition, a role for 
goosecoid in mediating RA taratoganie effect was studied at two different time 
windows E8 + 5 h and E1 0.5. BMP-4 tagether with other three homeobox genes 
Msx1, Msx2 and Hoxd-11 was analysed in the study for their possible role in 
mediating RA taratoganie effects. The mechanisms for the down-regulation of 
goosecoid and BMP-4 were studied in P19 and F9 mouse teratocarcinorma cells. 
3.1 goosecoid is required for the correct development of the 
submucous layer of the trachea. 
The homeobox gene goosecoid plays an important role du ring organogensis 
stages of mouse embryogenesis. This has been previously demonstrated for 
craniofacial and rib cage development (Yamada et al., 1995, 1997; Rivera-Perez et 
al., 1995). 
goosecoid null mutant mice died within 24 h after birth with air in their 
stomach. The absence of the submucous layer of the tracheal tunica mucosa most 
likely contributes to the neonatal death of homozygous null animals because of 
breathing problems. The submucous layer of the trachea contains secretory glands. 
These provide the mucus of the respiratory tract with highly glycosylated molecules, 
which protect airways and alveoli from injury and infections. ln fact, respiratory 
defects have been described previously in the goosecoid mutant mouse (Yamada 
et al., 1997). lt is weil established that the physiological functions of the tracheal 
mucosa and glands are essential for proper respiratory function. ln the case of 
cystic fibrosis, for example, which is the most common fatal hereditary disaase of 
Caucasian populations, the primary patholgical defect is a hypertrophy of the 
submucosal glands of the trachea (Scriver et al., 1995), which thus could be 
considered the reverse of the goosecoid phenotype. Therefore, further analysis of 
the goosecoid tracheal phenotype may provide insights in the understanding of the 
trachea-mucosal system. During development of the trachea the endodermal lining 
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of the laryngotracheal tube differentiates into the epithelium and glands of the 
trachea and pulmonary epithelium, whereas cartilage, connective tissue and 
muselas of the trachea are derived from the splanchnic mesoderm surrounding the 
laryngotracheal tube (Moore and Persaud, 1993). lt is conceivable that cell-cell 
interactions between these two tissues play a crucial role for the proper 
development of the trachea. The absence of the submucous layer of the tracheal 
tunica mucosa, therefore, likely represents a secondary phenotype. 
3.2 The role of goosecoid in the development of the shoulder 
and hip joint and associated adductor muscles of mouse 
embryos. 
No defects were reported in the appendicular skeleton of goosecoid mutant 
mice in the initial description of the mutation (Yamada et al., 1995; Rivera-Perez et 
al., 1995). Upon re-evaluation of the expression pattern I found that the earlier 
expression in the proximal limb bud at E10.5, and in the shoulder region at E12.5 
continues in the shoulder and hip joint regions, and in Iigaments and muselas 
attached to the humerus and femur (Fig. 3). Strictly related to this expression 
profile, I found a deletion of the fovea capitis femoris and the Iigament which is 
attached to this depression in the head of the femur, as weil as an 
underdevelopment of the adductur muselas extending to the femur. The hip joint is 
an anatomical and functional unit. Primitive condensed selerotomic mesenchyme 
transforms into cartilage that shapes in a genetically determined pattern to form the 
femur and os innominatum in continuity. ln human, the joint space develops by 
autolytic degeneration in the 7-8 week of gestation. By the 11th week, Iabrum and 
Iigamentum teres are differentiated from the joint cavity. (Ferrer-Torralles et al., 
1990). The homeobox gene goosecoid is the first transcription factor implicated in 
the normal development of the Iigament attached to the head of femur. 
Although a detailed analysis was not performed as yet, I would like to 
speculate that the expression in the perichondrium and mesenchyme around the 
cartilage primordia of the tibia and fibula (Fig. 3 G/H) may also result in defective 
Iigaments and muscle alignments. The bones, however, do form normally (not 
shown). The malformation of the innominate bone, particularly the os ischium, may 
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represent secondary effects, since - as is the case for most skeletal elements apart 
from neural crest derived craniofacial bones (Gaunt et al., 1993) - goosecoid 
expression is restricted to the perichondrium of the cartilage primordia, and the 
Iigaments and muscles attached to these bones. 
The function of goosecoid in limb development has also been investigated 
by a gain-of-function study in the chick limb bud (Heanue et al., 1997). Ovar-
expression of goosecoid by retroviral infection led to an alteration in the angle of 
femur outgrowth from the main body axis and the overall decrease in the size of 
goosecoid-infected limbs, with cartilage elements being small, misshapen and bent. 
Hox gene expression was down-regulated in goosecoid infected limbs. The 
combined evidence of these gain- and loss-of-function studies establishes 
goosecoid as an important determinator of vertabrate limb patterning. 
3.3 A role of goosecoid in the development of the genital 
"d ? n ge.
The significance of the expression of goosecoid in the genital is not clear at 
this time. Because homozygous mutant animals die 24 to 48 hours after birth, we 
were not able, for example, to assess possible abormalities of sexual functions. 
However, we would like to speculate on a role of goosecoid in epithelial cell fusions 
and the descent of the testis. 
goosecoid-expressing cells in the mesenchyme of the genital tubercule are 
fated to give rise to the external and internal muscles between which the fascia is 
located which is supposed to be the attaching tissue for the gubernaculum. ln both 
sexes, the descent of the gonads depends on the gubernaculum, a ligamentaus 
cord (Larsen, 1997). lt remains to be examined if the descent of testis and ovary is 
impaired in goosecoid null mutant newborn mice. 
Epithelial cell adhesion plays an important roJe within the three layers of the 
scrotal epidermis, stratum corneum, stratum spinosum and stratum germinativum, 
as weil as for the process of the fusion of the Iabiaserotai folds du ring development. 
Highly glycosylated cell surface molecules play a decisive role in this process. lt has 
previously shown that goosecoid mutant mice have altered cellular carbohydrate 
profilas at the site of the palatal-nasal fusion, and it was argued that these defects 
may constitute one of the elements for the Iack of fusion of the nasal septum with the 
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seeondary palate in the gooseeoid mutant (Yamada et al., 1997}. lt is, therefore, 
tempting to speeulate that abnormal eell-surfaee eharaeteristies are involved in 
abberant Iabiaserotai fusions in homozygous mutant miee. As goosecoid is 
expressed in the mesenehyme, and the defeets arise in the overlying epithelium, 
these defeets represent non-eeil autonomaus effeets. 
A non-eeil autonomaus funetion of goosecoid was previously deseribed in the 
eontext of axial development of the frag Xenopus during gastrulation. Eetopie 
expression of goosecoid in ventral blastomers of 32-eell trog embryos by 
mieroinjeetion of synthetie mRNA resulted in fate ehanges of neighbouring eells 
whieh were eonsequently reeruited into seeondary embryonie axes (Niehrs et al., 
1993). Thus, both during early and late phases of vertabrate embryogenesis 
goosecoid exerts some aspeets of its funetion through the modulation of eell-to-eell 
signaling, probably by transeriptional aetivation or repression of genes eneoding 
elements of signaling easeades. 
The goosecoid expression site in the Iabiaserotai mesenehyme eoloealized 
in part with the expression site of the androgen reeeptor (Croeoll et al., 1998}. 
Androgen reeeptor is a steroid hormone reeeptor that is required for proper male 
sex development. Hox genes are expressed in the developing genital tuberele 
(Dolle et al., 1991; Lyons et al., 1992; Zelster et al., 1996; Hostikka an Capeeehi, 
1998) and the requirement for Hoxa-1 0 for the reproduetivity of miee has been 
demonstrated (Satokata et al., 1995). However, Hox genes are expressed in the 
urogenital systerm in a broader domain than goosecoid. lt is not elear at this 
moment if there is a genetie interaetion among these genes in the development of 
the genital tuberele. lt will be interesting to investigate the genetie hierarehy of these 
genes in the development of the genital tubereule in the future. 
ln summary, there is a fairly good eorrelation between the sites of goosecoid 
expression at mid-embryogenesis and phenotypie alterations in mutant miee. 
However, as for the early phase of gene aetivity during gastrulation, where no axial 
defeets were deteeted in homozygous null embryos, there are struetures that 
express goosecoid during organogenesis and that are definitely normal in the 
mutant, as for instanee the ineus (eompare Fig. 3 AlB) and the seeondary palate 
(Gaunt et al., 1993; Yamada et al., 1995; Rivera-Perez et al., 1995}. This indieates 
that complementing gene aetivities should exist, as was postulated for the gastrula. 
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3. 4 A family of goosecoid related genes 
ln a systematic screen for goosecoid-related sequences a new gene has 
been cloned from genomic DNA by PCR using degensrate primers (Schweickert 
and Blum, unpublished). Recently, the same gene was also cloned by Galili et al. 
(1997), who have cloned and sequenced 38 kb of the syntenic region to the 
DiGeorge syndrome on mouse chromosome 16. The goosecoid-related gene, 
which was one of seven genas in this region, was named goosecoid-like ( Gsc~. 
Although expression of the human homolog of this gene was reported for the ninth 
and tenth week of development (Gottlieb et al., 1997), a detailed expression 
analysis of this gene was not performed as yet. Therefore it is not clear at the 
moment if this gene overlaps with goosecoid during gastrulation and/or 
organogenesis. However, the DiGeorge syndrome is characterized by defects 
related to branchial arches 111 and IV (Conley et al., 1979; Lammer and Opitz, 1986). 
Thus, if Gscl plays a role in the DiGeorge syndrome, it is likely to be expressed in 
the same region as goosecoid during organogenesis. 
Another goosecoid-related gene, GSX, was described in the chick (Lemaire 
et al., 1997). Within the homeo domain, goosecoid, Gscl and GSX are quite similar, 
with 74 to 87 percent identical amino acid residues. Outside the homeodomain, the 
sole region with significant homology is a seven amino acid stretch in the amino-
terminal part of the protein, which shows homology to engrailed and has been 
described as a repression domain (Smith and Jaynes, 1996). 
GSX and goosecoid during gastrulation in the chick are initially co-
expressed in Koller's sickle and in the primitive streak. The expression domains 
segregate in the process of gastrulation, such that goosecoid is expressed in the 
prechordal plate, and GSX in a non-overlapping manner in the developing neural 
plate (Lemaire et al., 1997). The individual roles of the different goosecoid genes in 
the process of gastrulation and organogenesis remain to be uncovered. 
Recently, early phenotypes in axial patterning have been observed in 
goosecoid and HNF-3ß compound knock-out mice. ln goosecoid -/- embryos, 
removal of one copy of HNF-3ß resulted in early phenotypes in day 8. 75 embryos, 
including reduction of the forebrain and severe ventralization of the brain, 
accompanied by loss or reduction of shh and FGF-8 gene expression (Filosa et al., 
Discussion 53 
1997). These phenotypes indicate that goosecoid tagether with other genes is 
required for axial patterning. 
3.5 The antagonism between the dorsal transcription factor 
goosecoid and the ventral signaling molecule BMP-4 
As a transcription factor, mause goosecoid has been shown to be a strong 
repressor (Danilov et al., 1998; Simth et al., 1996). This property of goosecoid is 
conserved from Orosorphila to mause (Mailhos et al., 1998). goosecoid protein can 
bind TAAT and ATTA DNA sequences. This has been shown for the binding of 
goosecoid to its own promoter (Danilov et al., 1998). A 1.5 kb BMP-4 promoter 
contains several T AAT sequences. ln Xenopus gastrula embryos, misexpression of 
goosecoid led to repression of BMP-4 (Fainsod et al., 1994). ln this study, I showed 
that BMP-4 promoter was able to mediate the repression by goosecoid. Although a 
detailed analysis has not been performed as yet, the data suggests that the 
repression of BMP-4 by goosecoid may be a direct regulation effect. lt remains to be 
seen if mutation of TAAT and ATTA sequences abolishes the repression of the 
BMP-4 reporter gene by goosecoid. 
ln early Xenopus embryos goosecoid and BMP-4 are expressed on opposing 
dorsal and ventral sides of the embryo (Fainsod et al., 1994; Steinbeisser et al., 
1995). Mis-expression of goosecoid in the ventral marginal zone of Xenopus 
embryo repressed BMP-4, and resulted in dorsalized embryos (Fainsod et al., 
1994). ln addition, it was shown that the secreted molecule chordin, which binds to 
BMP-4 and prevents its interaction with its receptors, is a (direct or indirect) target of 
goosecoid. Thus, goosecoid antagonizes BMP-4 by two mechanism, transcriptional 
repression and activation of the secreted molecule chordin. ln contrast, the nature of 
the repression of goosecoid by BMP-4 remains elusive. 
3.6 Neural crest cells are the primary targets of retinoic acid 
teratogenicity in early mouse embryogenesis 
goosecoid gene expression in the branchial region was altered at E10.5 
when embryos were treated with 20 mg I kg tRA at E8 + 5 h. This change in gene 
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expression correlated with specific taratagenie effects in the middle ear region, 
particularly affecting the tympanic ring and the three middle ear ossicles. For RA-
treatment a regime was chosen that was shown previously to result in alterations of 
the tympanic ring (Kessel, 1992; Mallo, 1997), because this bone was specifically 
lost in goosecoid mutant mice (Yamada et al., 1995; Rivera-perez et al., 1995). 
However, as free and non-metabolized RA does not persist in the embryo after 
gavage application for more than approximately 8 h (Satre and Kochhar, 1989), and 
because goosecoid is not present at E8.5, or expression is below the detection Ievei 
of radioactive in situ hybridization (Gaunt et al., 1993), the Observation of RA-
mediated changes in the expression of this gene seem to be an indirect event. 
A number of reports have demonstrated specific effects of RA on neural crest 
cell formation and migration in the mause (Mallo, 1997; Thorogood et al., 1982; 
Webster et al., 1986; Pratt et al, 1987; Lee et al., 1995; Gale et al., 1996). Mallo 
(1997) has shown in a recent paper that the middle ear ossides were sequentially 
lost by RA treatment in a small time window between E8 plus 4.5 and E8 plus 7.5 h, 
and that these phenotypic changes were related to the RA-dependent transient 
inhibition of neural crest cell migration. ln the light of this study I interpret the 
changes of goosecoid gene expression following RA treatment as the result of an 
altered population of neural crest derived mesenchymal cells in the branchial 
arches at E 1 0.5. The two different patterns, either restriction of goosecoid gene 
expression to the branchial cleft region or complete absence of transcripts from arch 
I and II, most likely reflect differences of developmental stages of embryos at the 
time of RA administration. 
This study was initiated because of the striking correlation of goosecoid 
expression at organogenesis, the knock-out phenotype, and specific RA taratagenie 
effects. A number of other genes have been described that - like goosecoid - are 
expressed in the forming middle ear bones and show specific malformations or 
deletions in knock-out mutant mice. The malleus, derived from arch I, was affected 
in mause mutants of the genes endothe/in-1 (Kurihara et al., 1994), msx-1 (Satokata 
and Mass, 1994), Hoxa 1 (Chisaka et al., 1992) and Mhox (Martin et al., 1995), the 
arch II derived ossides incus and stapes were malformed or absent in the case of 
endothelin-1 (Kurihara et al., 1994), Mhox (Martin et al., 1995), Hoxa 1 (Chisaka et 
al., 1992) and D/x-2 (Qiu et al., 1995), and the tympanic ring was changed or 
deleted in Mhox (Martin et al., 1995) and endothelin-1 mutants (Kurihara et al., 
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1994). lt will be of relevance to analyze the expression pattern of these genes 
following RA administration in the sensitive time window on the ninth day of 
pregnancy (Mallo, 1997) in order to identify other candidate genes that could 
mediate the RA teratogenicity, particularly in the ossicles where goosecoid is not 
expressed. As the majority of these other factors - like goosecoid - represent 
homeobox genes it seems possible that they might govern the formation of middle 
ear ossicles and tympanic ring by utilizing similar molecular pathways. lt is 
intriguing to analyze if and how these factors interact genetically in the development 
of the middle ear. 
Teratogenic effects of RA have been described for several susceptible 
phases of mouse embryogenesis. Administration shortly after implantation between 
E4.5 and E5.5 resulted in the duplication of the genital region (Rutledge et al., 
1994). Whereas goosecoid is not expressed at E4.5, we see transient expression in 
the developing genital eminence at E14.5 and E15.5 (Zhu et al., 1998). lt will be 
particularly interesting to analyze if duplications of the genitals by RA treatment is 
associated with ectopic expression of goosecoid mRNA. RA treatment during and 
after gastrulation led to homeotic transformations of the axial skeleton (Kessel and 
Gruss, 1991; Kessel, 1992}. As an effect of RA on goosecoid transcription has been 
described in Xenopus (Cho et al., 1991 }, RA effects du ring gastrulation and 
organogenesis (starting at E1 0.5) might in part be directly mediated by a change of 
goosecoid mRNA expression. 
3. 7 Perturbation of normal development at E1 0.5 by RA via 
alteration of expression of developmental genes 
Treatment of mouse embryos at E10.5 with a single dosage of 20 mg/kg tRA 
resulted in craniofacial defects, like cleft palate. Three successive times treatments 
of mouse embryos at the same stage with the same dosage led to forelimb long 
bone malformations without perturbation of caudal vertebrae development 
compared with a single dosage of 100 mg/kg tRA treatment (data not shown). This is 
consistant with the notion that RA teratogenic effect is dosage and stage dependent. 
Normal development of embryos is governed by coordinated expression of 
developmental genes. ln the facial development, a number of signaling molecules 
and transcription factors are determining components. goosecoid is expressed in 
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the craniofacial region (Gaunt et al., 1993) and required for normal development of 
craniofacial structures such as middle ear bones, mandible, tongue, and nose 
(Yamada et al., 1995; Rivera-Perez et al., 1995} which are potential targets of 
teratogens. As a signafing molecule, BMP-4 is an antagonist of goosecoid, as was 
shown in early trog development. A role for BMP-4 in craniofacial development is 
supported by the fact that BMP-4 heterozygotes mutant mice exhibits craniofacial 
malformations (Dunn et al., 1997). Ectopic application of recombinant BMP-2 and 
BMP-4 proteins changed the patterning of the developing chick facial primordia 
(Barlow et al., 1997}. 8oth loss- and gain-of-function studies implied that the dosage 
of BMP-4 is important for craniofacial development. The long arm of chromosome 
14q22.1-q23.2 was deleted in a patient with craniofacial defects (Lemyre et al., 
1998), and BMP-4 was mapped to this region of the chromosome. 
Mouse embryonie day 1 0.5 is one of the sensitive time windows for RA-
induced craniofacial defects. ln the present study both goosecoid and BMP-4 were 
found to be repressed by RA treatment at this stage. The discovery itself implicates 
goosecoid and BMP-4 as two of the target genes of RA in mediating teratogenic 
effect in craniofacial development. 
Other genes that have been found to be required for the development of 
craniofacial structures include the herneobox genes Msx1 and Msx2. The 
expression of these two transcription factors are colocalized with BMP-4, and they 
have been shown to be target genes of BMP-4 (Vainio et al., 1993). ln this genetic 
network, one part of the function of BMP-4 is mediated by the transcription 
factorsMsx1 and Msx2. Targeted mutagenesis of Msx1 in mouse embryos resulted 
in cleft palate and malformation of middle ear ossicles (Satokata and Maas, 1994) 
which is reminiscent of RA teratogenic effect. Recently it was found that Msx-1 and 
Msx2 were down-regulated in developing chick facial primordium following RA 
treatment (Brown et al., 1997). Jn my study, Msx1 and Msx2 were found to be 
repressed rapidly by RA in mouse embryos as weil. RA teratogenesis likely shares 
similar molecular mechanism among different vertabrate species. 
lnterestingly, all these genes are not only important for craniofacial 
development but also for limb development. All of the examined genes are 
expressed in the limb field. The function of these genes in limb development has 
been addressed by different approaches (Heanue et al., 1997; Belo et al., 1998; 
Zhu et al., 1998; Dunn et al., 1997; Ferrari et al., 1998}. Developing forelimbs are 
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particularly sensitive to RA if mouse embryos are exposed between E10.5 to E11.5. 
The rapid down-regulation of goosecoid, BMP-4, Msx1, Msx2 correlates with RA-
induced malformation of limbs. 
The vertabrate forelimb is divided into three zones: the stylopod (humerus), 
zeugopod (radius and ulna), and autopod (carpals, metacarpals and phalanges). 
RA treatment mainly results in malformation of humerus, radius and ulna in forelimb. 
lt almest phenocopies the defects caused by single or double Hoxa-11 and Hoxd-
11 mutations in mouse forelimbs (Davis et al., 1995). Activation of Hox genes in the 
developing limb is in a spatial and temporal sequence with the 3' genes expressed 
first and the 5' genes last, creating a transcriptional cascade of Hox-9, 10, 11, 12 
and then 13 (lzpisua-Belmonte and Duboule, 1992). The development of limbs 
occurs in a sequence such that it proceeds through the humerus, the ulna and then 
anteriorly through the wrist, and that the anterior distal carpals are the last to be 
made (Duboule, 1994). Hox 1 0-13 genes specify the development of each part of 
limb in a sequential manner from humerus to autopod. RA specific teratogenic effect 
on humerus, radius and ulna are presumably mediated either directly or indirectly 
by alteration of the expression of certain Hox genes in the limb. 
Because the phenotypes of Hoxa-11 and Hoxd-11 closely resemble RA 
teratogenic effect at E 10.5 on forelimb, both genes became interesting candidate 
molecules for the study. Hoxd-11 is expressed at the right time and the right place 
when and where RA teratogenesis occurs in the developing iimb. ln the study I 
showed that the expression of Hoxd-11 in the limb bud was repressed by RA 
treatment. This result suggests a role for the gene in mediating RA teratogenicity in 
developing limbs, especially in radius and ulna. RA treatment led to shortening and 
expansion of ulna and radius bones. This malformation is similar to the knockout 
phenotypes of Hoxa-11 and Hoxd-11, but not identical. As observed for goosecoid 
and BMP-4, RA repression of Hoxd-11 gene may be also in a ligand-dependent 
way. Ligand-dependent repression of genes is a temporary process. lt is primarily 
different from gene targeting in embryos. RA teratogenesis involves a large 
spectrum of genes in embryos, like goosecoid, BMP-4, Msx1, Msx2 and Hoxd-11. 
RA teratogenesis is a result of the alteration of all the genes caused by RA 
treatment. 
Other signaling molecules and transcription factors also play important roles 
in craniofacial and limb development. The signaling molecule shh is implicated in 
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epithilial and mesenchymal interactions in craniofacial, body axis and limb 
development. Targeted disruption of shh revealed a critical role in patterning 
vertabrate embryonie tissues (Chiang et al., 1996}. ln shh null mutant mice the 
normal facial structures like nose, eyes and oral structures were not identifiable, and 
the sole remaining external feature of the mutant head is a proboscis-like extention 
that protrudes from the rostral midline. The development of limbs was severely 
affected as weil. Application of RA in chick facial primordia down-regulated the 
expression of shh and delimits the out-growth of the facial primordium (Helms et al., 
1997}. Contrary, local application of RA to developing limb buds up-regulates shh 
expression and creates a new ZPA, and therefore Ieads to duplication of digites 
(Riddle et al., 1993}. The knock-out phenotype of the transcription factor AP-2 
demonstrated important roles for craniofacial and limb development (Zhang et al., 
1996; Schorle et al., 1996). One of the distinct phenotypes is the Iack of the radius 
(Zhang et al., 1996) although not with 100 percent penetrance. This phenotype 
resembles to some extent the phenotype of Hox11 knock-out mice and RA 
teratogenic effect. ln chick embryos it was shown that AP-2 was repressed by local 
application of RA (Shen et al., 1997}. lt seems that RA execute its teratogenic effect 
by alteration of expression of numerous key developmental genes. 
Functional analyses of AARs and RXRs by gene targeting not only uneavered 
the important functions of these genes in normal development but also shed light on 
the functions of some of the receptors in mediating RA teratogenic effects. Mice null 
for retinoic acid gamma receptor (RARy) exhibit axial defects, including homeotic 
transformation of several vertebrae (Lonhes et al., 1993}. lnterestingly, RARy null 
mutants are completely resistant to RA-induced spina bifida (Lonhes et al., 1993}, 
neural tube defects and craniofacial malformations (lulianella and Johnes, 1997}, 
suggesting that this receptor specifically transduces at least a subset of the 
teratogenic effects of retinoids in spina bifida, neural tube and craniofacial 
development. lnterestingly, another retinoic acid X receptor (RXRa} is a component 
in the teratogenic process in the limbs (Sucov et al., 1995}. Mouse embryos 
homozygous for a mutation in the RXRa gene appear normal in limb development 
although they have defects in heart development (Sucov et al., 1994; Kastner et al., 
1994). RA treatments that cause limb defects in 1 00% of wild-type embryos fail to 
elicit malformations in RXRa homozygotes, and heterozygous embryos are 
Discussion 59 
intermediate in sensitivity to RA, suggesting the importance of RXRa gene dosage in 
limb teratogenesis. 
These two discoveriss indicate clearly that RA teratogenesis is under 
genetical control. lt is not a simple mass killing of cells by excess RA. Therefore, it is 
interesting to uncover the genes in mediating RA teratogenic effect and reveal the 
mechanisms of how RA teratogenesis takes place. ln this study, the expression of 
goosecoid, BMP-4, Msx1, Msx2 and Hoxd-11 were analysed in both RXRa+/- and 
RXRa-/- genetical background with and without RA treatment of mause embryos. All 
of the genes examined were normally expressed in both RXRa+/- and RXRa-/-
mouse embryos. Although RXRa+ mause embryos had heart defects, expression of 
BMP-4 in developing heart was not changed in these embryos. All of the five genes 
were repressed following RA treatment of RXRa+/- mause embryos, suggesting that 
these genes are involved in the RA teratogenesis processs. However, in RXRa-/-
genetic background, Msx2 was not repressed by RA and BMP-4 was less repressed 
by RA than in RXRa+/- mause embryos, suggesting that Msx2 and BMP-4 are down-
stream of RXRa in mediating RA teratogenic effect. They might be two of the genes 
downstream of RXRa in transducing RA teratogenesis in limb. RA signaling is 
transmitted by RAR and RXR receptors. lt is conceivable that inappropriate 
activation of these receptors in developing embryos by RA causes either ectopic 
expression or down-regulation of a large number of developmental genes that 
would Iead to malformation of developing embryos, like the alteration of expression 
of the genes discovered in this study. lnvestigation of the mechanism how these 
genes are repressed by RA could help select those ligands that are effective in 
treatment of disease without inducing RA teratogenesis at the same time. 
3.8 Mechanisms of down-regulation of goosecoid and BMP-4 
by RA 
Down-regulation of both goosecoid and BMP-4 by RA in mause embryos at 
E1 0.5 was achieved 4 hours following RA treatment. A 4.5 kb mause goosecoid 
promoter-luciferase reportergenewas found tobe able to mediate RA repression in 
P19 cells. The repression appears to be in part mediated by RXR since 
cotransfection of RXR is necessary for the repression, and because a dominant 
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negative RXRa that Iacks the AF-2 transactivation domain abolishes the repression. 
The latter result indicates that the AF-2 domain is required for the repression of 
goosecoid by RA. 
Several studies have demonstrated that RA can repress the expression of 
genes by antagonizing AP-1 activity (Schüle et al., 1991; Nieholsan et al., 1990). 
However, no consensus AP-1 binding site was found in 4.8 kb of the mouse 
goosecoid promoter. This suggests that other mechanisms may be involved in the 
repression of goosecoid by RA. Since goosecoid is not expressed in P19 cells, it is 
not possible to study the regulation by analysing endogenaus goosecoid 
expression following RA treatment in P19 cells. 
ln mouse embryos BMP-4 was repressed by RA treatment. This effect was 
also seen on the endogenaus BMP-4 gene in F9 cells. The BMP-4 promoter 
contains AP-11ike sites, but one component of the AP-1, c-JUN is not expressed in 
F9 cells (van Dam et al., 1995). Nuclear protein extract from F9 cells can not bind to 
consensus AP-1 response elements (Diccianni et al., 1992), indicating that F9 cells 
do not have AP-1 activity. Therefore, down-regulation of BMP-4 by RA in F9 cells is 
not due to antagonizing AP-1 activity by RA receptors. The fact that TPA did not 
increase the transcription of BMP-4 in F9 cells further supports this notion. Down-
regulation of BMP-4 by RA does not require de novo protein synthesis, implying that 
the down-regulation may not be due to up-regulation of a repressor or repression of 
an activator by RA. 
ln F9 cells, the RARa specific Iigand AmBO can repress BMP-4 expression 
efficiently, while no repressionwas found with a RXR specific Iigand. This suggests 
that RXR may not mediate the repression of BMP-4 expression alone. lt does not 
exclude the possibility that RAR and RXR form heterodimer to transduce the 
repression of BMP-4 by RA. 
Recently, it was reported that TR4, an orphan receptor, was up-regulated by 
RA in F9 cells (Lee et al., 1998). lt recognizes the AGGTCA direct repeat (DR) of the. 
hormone response element spaced by 1 and 5 base pairs (DR1 and DR5), which 
are also the response elements for RAR and RXR. TR4 represses RA-induced 
transactivation by competing the DNA binding site with RAR and RXR (Lee et al., 
1998). ln the BMP-4 promoter there is DR1 site that has been shown tobe bound by 
another type of orphan receptor, COUP-TF1 (Feng et al., 1995). However, COUP-
TF1 was not up-regulated in F9 cells by RA, so it is unlikely that down-regulation of 
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BMP-4 is mediated by COUP-TF1. The DR1 in the BMP-4 promoter could be a 
potential binding site for TR4. lt remains to be seen if TR4 is the mediator for the 
repression of BMP-4 in F9 cells by RA. 
A. Embryonie day 7.5 to 8.5 
RXR.RAR ~ _. ~ ~ Ectopic expression Posterior 
RA __.. r' ~ of Hox genes __.. transformation 
RARE 
B. Embryonie day 8.0 + 4 to 7 h 
. ___j Neural crest cell . . RA --, migration ~ Malformation of m1ddle ear bones 
C. Embryonie day 10.5 to 11.5 
BMP-4 --.,....Msx1 l T Msx2 
RA . Malformation of mouse embryos 
RARIR goosec01d __.. (includlng limb long bone defects) 
Hoxd-11 
Fig. 25. A model for RA teratogenic effect on developing mouse embryos at 
different stages. 
RA teratogenicity is dosage and staga-dependent for developing embryos. lf 
mouse embryos are exposed to RA from E7.5 to E8.5, RA induces ectopic 
expression of Hox genes. Ectopic expression of Hox genes results in homeotic 
transformation of vertebrae (Fig. 25 A). Up-regulation of many Hox genes is due to 
ectopic activation of RA receptors that will bind to RAREs in the regulatory 
sequences of Hox genes. Treatment from ES + 4 to 7 hours inhibits neural crest cell 
migration and causes different types of malformations of middle ear bones (Fig. 25 
B). lf mouse embryos are treated at E 10.5 to E 11.5 with RA, RA down-regulates 
many genes, such as, goosecoid, BMP-4, Msx1, Msx2, Hoxd-11 and others. This 
treatment results in cleft palate, limb defects (Fig. 25 C). Down-regulation of genes 
by RA could be mediated via antagonizing AP-1 activity by RARs or RXRs. 
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Alternatively, RA may activate transcription factors that act as potent repressors. 
Another possible mechanism may involve in the degradation of certain general 
transcription factors following RA treatment, like SP1 that would result in down-
regulation of many genes. 
Understanding of the mechanisms of RA teratogenicity is particularly clinically 
relavent. lt will help to develop and screen for RA analogs that exhibit the beneficial 
feature for the treatment of disaase while lacking teratogenic potential. 
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4. Materials 
All of the chemieals used in the study was of high quality from different companies. 
Below is only a list of special reagents and materials that were utilized in this study. 
Reagents for radioacitve in situ hybridization: 
Reagent 
Tespa (3-Aminopropyltriethoxy-silene) 
ATP,GTP,CTP 
Silicone solution 
Triethanolamine 
Hypercoat nuclear emulsions 
Sodium Thiosulfate 
Entallan Neu 
Mayer's Hematoxylin solution 
RNase inhibitor 
a-35S-UTP 
DNA Plasmids 
0 
Company 
Sigma 
Boeringer Manharn 
Serva 
Sigma 
Amersham 
Sigma 
Merk 
Sigma 
Amersham 
Amersham 
1. 1.2 kb goosecoid cDNA in pBluescript vector (from Dr. Martin Blum): for antisense RNA 
probe, digest the plasmid with Sacl and transcribed with T3 RNA polymerase; for sense 
control probe, digest the plasmid with Hind III and transcribe with T7 RNA polymerase. 
2. 1.55 kb BMP-4 full length cDNA in pSP72 vcctor (ampicillin resistant, from Dr. Brigit 
Hogan): for antisense RNA probe, digest the plasmid with Ace I and transcribe with T7 
RNA polymerase; for sense RNA probe, linearize with EcoRV and use Sp6 RNA 
polymerase for transcription. 
3. Msx1 cDNA with Sph fragment deleted in pTZ19 vector (from Dr. Richard L. Maas). 
Linearize the plasmid with EcoNI and transcribe with T7 RNA polymerase to generate 
antisense probe (about 500 bp). 
4. Msx2 fulllength cDNA in PCR II vector (from Dr. Richard L. Mass). Linearize the plasmid 
with BamHI and transcribe with T7 RNA polymerase for antisense probe; and digest the 
plasmid with EcoRI and transcribe with Sp6 RNA polymerase for sense probe. 
5. Hoxd-11 plasmid was got from Dr. Pascal Dolle. Antisense probe for Hoxd-11 was 
transcribed from Hindlll-digested plasmid with T7 RNA polymerase, and sense probe was 
• 
transcribed from BamHI-digested plasmid with Sp6 RNA polymerase. 
6. GAPDH plamid was linearized with Pstl to isolate 1.3 kb GAPDH insert for Northern blot 
probe. 
7. mRXRa, mRXRß, mRXRyand dnRXRa were offered by Prof. Dr. Pierre Chambon. 
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Ritinoic acid 
All-trans retinoic acid 
9-cis retinoic acid 
Am80 and SR11237 
PCR primers 
Materials 
Sigma 
Sigma 
Dr. Hinrieb Gronemeyer 
PCR primers for emplifying a 1.5 kb BMP-4 promoter: 5' primer: 5'-GCT CGA GAA 
TTC GCT AGG TAG AC-3'; and 3' primer: 5'-TAA GCT TTT AGG CCA TGT AGA-3'. 
PCR primers for genotyping RXR mutant embryos: primer 1: 5'-ACT GCC TGA TCG 
ACA AGA GAC AGC G-3'; primer 2: 5'-GGG CTC TGC TGA GCA GGA GGA CA-3'; 
primer3: 5'-GCC CAT CCC TCA GGA AAT ATG-3'; primer4: 5'-GAT CAG CAG CCT CTG 
TTC CAC ATA C-3'. Wild-type embryos gave rise to a 250 bp DNA fragment, heterozygous 
RXR embryos showed a 300 bp and a 250 bp DNA fragment, and homozygous RXR embryos 
had a 300 bp DNA fragment. 
Mouse embryos 
1. Wild-type mouse embryos were derived from matings between C57BL/6J strain mice. 
2. goosecoid null mutant embryos were provided by Dr. Gen Y amada. 
3. RXRa +1- and RXRa -/- mouse embryos came from matings between RXRa +1- mice with 
FP104 genetic background (generously provided by Prof. Dr. Pierre Chambon's lab). 
Methods 65 
5. Methods 
Preparation of competent cells 
Inoculate a single colony of XLl blue cells from an agar plate into 2.5 m1 of LB or SOB 
medium, grow overnight at 37 oc. Subculture the cells from ovemight growth in 1:100 ratio 
(i.e. add the 2.5 ml overnight growth cells into 250 m1 SOB + 20 mM MgS04) in SOB +20 mM 
MgS04 and grow the culture until OD590=0.4- 0.6 (about 3.5 to 4.5 h). Centrifuge the culture 
at 5000 rpm for 5 min at 4 oc. Gently resuspend pellet in 100 m1 ( 40 m1 for 100 m1 culture in 
step 2) ice cold TFB 1 and work on ice from this step onward. Incubate on ice for 5 min. 
Centrifuge at 5000 rpm for 5 min at 4 °C. Gently resuspend the pellet in 10 m1 (4 m1 for 100 ml 
culture from step 2) ice cold TFB2. Incubate on ice for 40 - 50 min. Aliquote the cells with 
chilled pipette tip in 100 111 volume in ice-colded eppendorf tubes and immediately freeze in 
liquid N2. Store at -80°C. 
Solutions: 
LB medium: Per liter, add 
bacto-tryptone 10 g 
bacto-yeast extract 5 g 
NaCl 10 g 
add distilled H20 to 950 ml, adjust the pH to 7.0 with 5 N NaOH ( about 0.2 ml 
). Adjust the volume of the solution to 1 liter with distilled H20, and autoclave. 
SOB medium: For one liter, in 950 ml distilled H20 add 
bacto-tryptone 20 g 
bacto-yeast extract 5 g 
NaCl 0.5 g 
250 mM KCl 10 ml 
Adjust the pH to 7.0 with 5 N NaOH ( about 0.2 rnl ). Add dH20 to 1liter. 
Dissalve all components and autoclave. 
Just before use, add 5 ml of a sterile solution of 2 M MgC12• Both KCl and MgCl 
are made sterile by autoclaving. 
TFB 1: for 100 ml RbC12 1M 10 rnl 
MnC12 1M 5 rnl 
KAc 1M 3 rnl 
CaC12 1M 1 m1 
Glycerol 15 rnl 
H20 66 rn1 
add one drop of HAc to pH 5.8, sterilize by filtering through 0.21-lm 
filter. 
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TFB2: for 100 ml 
Transformation 
Methods 
1M MOPS (pH 6.5 with 1N KOH) 
1M RbC12 
1M CaC12 
Glycerol 
H20 
sterilise by filtering through 0.2J.tm filter. 
1rnl 
1rnl 
7.5 ml 
15rnl 
75.5 ml 
Add plasrnid DNA (1 - 5 J.tl, up to 0.1 J.tg DNA is enough) to 100 J.tl competent cells and rnix 
with pipette tip. Store the tubes on ice for 30 min. Controls include competent bacteria that 
receive no plasrnid DNA and competent bacteria that receive a known amount of the standard 
preparation of supecoiled plasrnid DNA. For cloning, two enzyme-digested plasrnid after 
ligation should be included as a negative control. Transfer the tubes to a rack placed in a 
circulating water bath that has been preheated to 42 °C. Leave the tubes in the rack for exactly 90 
seconds (37 oc for 40 seconds also works). Don't shake the tubes. Rapidly transfer the tubes to 
an ice bath. Allow the cells to chill for 1-2 rnin. Add 800 J.Ll LB medium to each tube. Transfer 
the tubes to a shaking incubator set at 37 oc. Culture the bacteria at 37 oc with 1ess than 225 
cycles/rnin for 45 rnin. Add all of each in 200 ml LB ampicilin or other antibiotics depending on 
the plasrnid ( 100 J.tg/rnl ) medium for maxiprep growth. Or centrifuge each tube at 2500 rpm for 
3 minu, remove about 700 J.tl medium and resuspend the bacteria pellet in the rest 200 J.tl 
medium and plate all of each onto an agar LB medium plate containing 100 J.tg/rnl ampicillin for 
selection of positive clones. For maxiPrep, grow bactieria at 37 oc with 250 rpm/rnin 
ovemight. For cloning, invert plates and grow at 37°C ovemight. 
MiniPrep of plasmid DNA 
Pick colony from plate, grow ovemight at 37 °C in 3 ml LB -ampicillin medium . Transfer 1.5 
ml into an Eppendorf tube, and spin 1 min at room temperature. Suck off the supematant. Add 
100 J.tl Solution 1 to bacterial pellet, vortex until suspended. Open lid and add 200 J.tl Solution 
2. Close lid, and invert tube 3-4 times. Add 150 J.tl Solution 3, close Iid, turn in inverted 
position for 10 sec. Spin 5 rnin at RT. Transfer the supematant to fresh tube. Add equal volume 
( 450J.tl) phenol-ch1oroform (1: 1 ), vortex, spin 2 min at RT. Transfer aqueous phase to new 
tube, add 1 ml ethano1, vortex, incubate 2 min at RT. Spin 5 rnin at RT, wash pellet with 70% 
ethanol (don't vortex). DNA pellet is dried in air. Dissolve DNA in 50 J.tl TE-RNAase A 
(20J.tg/ml), vortex and spin down. Digest about 5 J.tl for verifying positive clones. Run on 
agarose gel. 
100 ml Solution 1: 5 ml 1M Glucose 
2.5ml 1M Tris.Cl pH 8.0 
2 ml 0.5M EDTA pH8.0 
Methods 
dd H20 to 100 ml 
Always prepare fresh Solution 2, for 200 ~1, add 40 ~1 1N NaOH 
10 ~1 20% SDS 
150 ~1 ddH20 
100 ml Solution 3: 60 ml 5M Potassium acetate (KAc) 
11.5 ml Glacial acetic acid 
28.5 ml 
MaxiPrep of DNA 
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Maxi preparations of plasmid DNA were done by either QIAGEN column and reagents or 
Nucleobond column and reagents. Inoculate 200 ml LB ampicillin ( 100 ~g/ml) medium with 
bacteria carrying the plasmid. Grow overnight at 37°C. Next day add bacteria culture to a plastic 
tube, centrifuge for 10 min/5000 rpm/4 °C. Drain the pellet by inverting the tubes. 
QIAGEN protocol: 
Resuspend the bacteria pellet in 10 ml of buffer P 1 + 1000 ~g RN ase A. Add 10 ml of buffer 
P2, mix gently and and incubate at room temprature for 5 min. Add 10 ml of buffer P3, mix 
immediately but gently , and centrifuge in a 30 ml-volume tube at 4 oc for 45 min with a speed 
of 12000 rpm. Equilibrate a QIAGEN-tip 500 with 10 ml of buffer QBT and allow it to empty 
by gravity fow. Po ur the supernatant from the centrifuge tube through a cotton cloth to the 
equilibrated QIAGEN-tip and allow it to enter the resin by gravity flow. Wash the QIAGEN-tip 
with 30 ml ofbuffer QC. Blute the DNA from the tip with 15 ml buffer QF. Precipitate the DNA 
with 0.7 volumes of isopropanol (10.5 ml ), previously equilibrated to room temperature, and 
centrifuge in a 30 ml-volume glass tube at 4 oc for 30 min at a speed of 9000 rpm. 
Composition of buffers 
Buffer P1 50 mM Tris/HCl, 10 mMEDTA, pH8.0, add RNase A to 100 ~g/ml, store at 4°C 
Buffer P2 200 mM NaOH, 1 %SDS 
Buffer P3 2.55 M KAc, pH4.8 
Buffer QBT 750 mM NaCl, 50 mM MOPS, 15% ethanol, pH 7 .0, 0.15% Triton X-100 
Buffer QC 1.0 M NaCl, 50 mM MOPS ( pH7.0, 15% ethanol, pH 7.0 
Buffer QF 1.25 M NaCl, 50 mM Tris/HCl ( pH8.5 ), 15% ethanol, pH 8.2 
Store buffers P2, P3, QBT, QC,and QF at room temprature. 
Nucleobond protocol as described by the manufacturer. 
Digestion of DNA with restriction enzymes 
Digest 1 to 10 ~g DNA with restriction enzymes in a volume of 20 to 100 ~1. Restrietion 
enzyme could be 1 to 3 ~1 ( 10 to 30 U ). One U of restriction enzyme is designated as the 
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amount of the enzyme that can digest 1 J.Lg J.DNA at 37 oc within 1 hour. The volume of the 
total restriction enzymes in the reaction tube should not exceed 10% of the total volume. 
Otherwise, the glycerol from the stockenzymewill inhibite the reaction. Add corresponding 10 
x restriction buffer in 1/10 of the total reaction volume. Add ddH20 to the desired reaction 
volume. Vortex the reaction mixture and spindown shortly. Incubate the tubes in 37 oc warm 
room for 1 hour to overnight ( For certain enzymes, other special reaction temperatures are 
required). Here is an example of digestion of 5 J.Lg DNA (lJ.Lg/Jll plasmid DNA in TE buffer) 
with Hindill restriction enzyme: 5 J.Ll plasmid DNA 
10 J.Ll 10 x restriction buffer E 
2 J.Ll Rind III ( 10u/J.Ll) 
83 J.Ll dd H20 
vortex and spin down, incubate at 37 oc for 1 hour or longer. 
Repairing 3 ~ or 5 ~ overhanging ends to generate blunt ends 
In a 20 Jll reaction, digest 0.1 to 4 J.Lg DNA with a restriction endonuclease. Add 1 J.Ll of 0.5 
mM of each dNTP. Add 1 to 5 U of the Klenow enzyme and incubate at 30 oc for 45 min. Stop 
the reaction by heating to 7 5 oc for 10 min or by adding 1 J.Ll of 0.5 M EDT A. 
Dephosphorylation of DNA 
Calf intestine phosphatase (CIP) catalyzes the hydrolysis of 5'-phosphate residues from DNA, 
RNA, and rib and deoxyribonucleoside triphosphates. The dephosphorylated products possess 
5'-hydroxyl termini which can subsequently be radioactively labled using [y-32P]ATP AND T4 
polynucleotide kinase. On the other band, dephosphorylation of vector alone can prevent it 
from self-ligation. CIP requires Zn2+ for activity. CIP is readily inactivated by heating to 70°C 
for 10 min. CIP reaction conditions for dephosphorylation of DNA: 
For 50 J.Ll reaction: 
20 mM Tris/HCl, pH 8.0 
1 mMMg Cl2 
1 mM ZnC12 
1 to 20 pmol DNA termini (1J.Lg of a 3kb linear DNA contains 1pmol of 5' 
termini.) 
0.1 U CIP 
Incubate at 37 oc for 30 min, and stop reaction by heating to 75 oc. 
Extraction of protein from nucleic acid 
Add an equal volume of phenol/chloroform ( 1: 1 ) to DNA solution, vortex and centrifuge at 
13000rpm for 5 min in Eppendof centrifuge. DNA is in upper phase ( aquouse phase ), and 
protein is in inter phase. Carefully transfer the upper aquous phase to a new tube and precipitate 
the DNA from the solution. 
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Electrophoresis of DNA in agarose gel 
Prepare 1% or 1.5% agarose gel in 1 X TBE buffer in a volume of 50 or 300 ml in microwave 
until boiling. Cool down the agarose gel solution to about 60°C, and then add 2.5 ~1 of 10 
mg/ml ethidium bromide to 50 ml gel solution. 1% gel is suitable for separating 700 bp to 6 kb 
DNA fragments, and 1.5% for shorter fragments like 200 bp to 2 kb. Add 10 x loading buffer 
in a volume of 1/10 of the DNA solution to DNA sample. Load DNA solution in 1 x loading 
buffer to the gel slots. Run the gel in 1 x TBE buffer at constant voltage around 120 V. 
Visualize DNA fragments under UV light. 
10 X TBE buffer ( 1liter ): Tris base 108 g 
Boric acid 55 g 
N~EDTA.2H20 9.3 g 
H20 to 1000 ml, filter. 
Precipitation and purification of DNA fragments 
Precipitation of DNA: Add 10 X TNE buffer in a volume of 1/10 of the DNA solution. Then 
add cold ethanol in a volume of 2.5 times of the total DNA solution (including 10 X TNE 
buffer) volume. Vortex and centrifuge at 13000 rpm for 10 rnin. Discard solutions carefully and 
keep the DNA pellet on the bottom of the Eppendorf tube. Wash the DNA pellet carefully with 
70% cold ethanol (don't vortex). Dry the pellet in air. 
Purification of DNA fragments: Cut the DNA fragment from agarose gel and put it in a Spin-X 
column (Costar, Corning Costar Corporation, USA) and spin the DNA down at 13000 rpm for 
10 rnin in Eppendorf centrifuge. The eluted DNA solution could be used directly for cloning. 
Another very effeciant DNA purification way is to use DNA purification kit ( Biozym, Germany 
): Cut DNA band and mearsure the volume ( 100 mg = 100 ~1 ). For TBE gel, add 1/2 volume 
of MELT, then 4.5 volume SALT. 55 °C, 5 rnin incubation and rnix ( agarose must be 
completely dissolved ). Vortex BIND. add 5 ~1 +1 ~1/~g DNA BIND ( i.e. 6.5 ~1 BIND for 
1.5 ~g DNA ). 5 min incubation at room temerature, mix. Spin 5 seconds, dicard the 
supernatant. Resuspend the pellet in 1 ml W ASH. Spin 5 seconds, discard the supernatant. 
Short spin, discard the supernatant. Dry the pellet. Add 10 - 20 ~1 ddH20 or TE ( pH7.8 ) 
buffer, resuspend. 5 rnin incubation at room temperature. 1 rnin spin, remove the DNA solution 
to a new tube and soter DNA solution at 4 oc or - 20 °C. 
Ligation reaction 
Ligation reactions are usually donein a 10 ~1 volume. Add 1 ~1 10 X T4 DNA ligase buffer, 1 
to 4 J..Ll of DNA solutions, 1 ~1 5 rnM ATP, 1 ~1 T4 DNA ligase, and add ddH20 to a final 
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volume of 10 J..Ll. Mix well and leave the reaction tubes in a 16°C water bath overnight. Perform 
transformation next day with 5 J..Ll of the ligation solution. 
Sequencing 
Use the Thermo Sequenase radiolabeled terminator cycle sequencing kit ( Amersham Life 
Science). Components of the kit: Thermo sequenase DNA polymerase, 4 U/J..Ll, 0.0006 
U/J..Ll Themaplasma acidaphiZum inorganic pyrophosphatae, 50 mM Tris.HCI, pH8.0, 1 mM 
dithiothreitol (DTT), 0.1 mM ethylenediamine tetraacetic acid (EDTA), 0.5% Tween-20, 0.5% 
Nonide™P-40, 50% glycerol. Reaction buffer: 260 mM Tris.HCI, pH9.5, 65 mM MgC12• 
dGTP nucleotide master mix: 7.5 J..LM dATP, dCTP, dGTP, dTTP. diTP nucleotide 
master mix: 7.5 J..LM dATP, dCTP, dTTP, 37.5 J..LM diTP. Stop solution: 95% formamide, 
20 mM EDTA, 0.05% bromophenol blue, 0.05% xylene cyanol FF. 
Brief description of the protocol of seguencing with above mentioned kit. Choose the 
termination master mix, dGTP or diTP. dGTP is fine for normal GC content sequence, while 
diTP is designed for GC rieb sequence. Prepare the 4 termination mixes using 2.0J..Ll of 
terrnination master rnix and 0.5J..Ll of labeled ddNTP for each sequence (see below): 
1 sequence 5 sequence 
G A T c G A T c 
Termination master mix(J..Ll) 2.0 2.0 2.0 2.0 10 10 10 10 
a-33P ddGTP 0.5 2.5 
a-33P ddATP 0.5 2.5 
a-33P ddTTP 0.5 2.5 
a-33P ddCTP 0.5 2.5 
Total 2.5 2.5 2.5 2.5 12.5 12.5 12.5 12.5 
Dispense terrnination mixes: Iabel four tubes ('G', 'A', 'T', 'C') for each sequence. Fill tubes 
with 2.5J..Ll of the appropriate termination rnix prepared above and cap. Prepare the reaction 
rnixture: combine the following, 
Reaction buffer 2J..Ll 
DNA ( 0.5 -1J..Lg) _Jll 
Prime ( 2.5 pmol) _Jll 
ddH20 _Jll 
Thermo Sequenase™ DNA polymerase 2J..Ll 
Total 20J..Ll 
Mix weil 
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Cycling termination reaction: Transfer 4.5 ~1 of the template and polymerase mixture from last 
step to each termination tube ( 'G', 'A', 'T', and 'C'). Mix well. Cap and place the tubein the 
thermal cycling instrument. Cycle 30-60 times as follows: 
dGTP diTP 
95°C, 30s 
55°C, 30s 
72°C, 1 min 
Stop the reaction by adding 4 ~1 of stop solution. 
95°C, 30s 
50°C, 30s 
60°C, 5-10 min 
Heat samples to 70 oc for 2-10 min immediately before loading onto sequencing gel. 3 -5 
~1/lane. 
Preparation and running of a sequencing gel: Clean the plates of sequencing apparatus, wash 
both plates with detergent. Get rid of detergent and H20 with Kimwipes. Use ethanol to clean 
the glass (which doesn't have any attachments), then clean it with H20, then dry carefully. 
Siliconize the ear plate with SIGMACOTE (Sigma), and air dry. Assemble the plates wtih 
spacers so that the thicker part (0.4mm) is down and the thinner part (0.25mm) is up. Put the 
rubber slice inside the casting tray, one on the bottom, the other standing on the opposite to the 
screw, and put a a strip of Whatman 3 mm paper on the rubber layer on the bottom. Prepare the 
polymerizing solution: 
Small gel 
Urea mix 90 ml 
big gel 
150ml 
750 ~1 
300 ~1 
10% APS 
TEMED 
375 ~1 
150 ~1 
Po ur it quickly on the paper in the tray, and then put the assemb1ed g1ass apparatus in the 
casting tray. Let the solution enter into the interspace between the plates, then fix with the 
screw. Let it polymerize for 10 min. Prepare gel solution: 
Ureamix 
10% APS 
TEMED 
Small gel Big ge1 
90ml 150 ml 
750 ~1 900 ~1 
75 ~1 90 ~1 
Mix well, and then pour it slowly into the space between the two plates. Then put the comb 
upside down ( about 0.4 cm ) between the two plates, and clip both plates well. Let the ge1 
polymerize for at least 1 h. Disassemble the lower tray and put the glasses into gel running tray. 
Add 1xTBE buffer. Take away the comb, and add 1xTBE. Use syringe with a needle to 
displace urea, and add 2 ~1 stop buffer in order to see the upper line of the gel clearly. Insert the 
right side of the comb slightly into the gel and the sequencing reaction solution will be added 
into each of the comb spaces, and leave the comb there, and add 2 ~1 stop buffer to each of 
several slots to check if leaky or not. Load 2 111 stop buffer to each lane, and pre-run the gel 
(small gel: 100 w,50 °C, big gel: 120 W, 50 °C) about 15 min until the gel reaches 50 oc. After 
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pre-run, displace Urea again with a needle just before loading the samples. Sampies should be 
heated with open Iid at 70 oc for 10 - 20 min and then load them immediately onto sequencing 
gel. Run the big gel at 120 W, 50 °C, the small gel at 100 W, 50 oc about 2.5 h until the first 
blue band to the bottom, and the second blue band to 2/3 of the gel. Dispose the lower 1xTBE 
as radioactive waste, upper 1xTBE as normal waste. Disassemble the plates carefully, leave the 
gel on one side of the plate( without ears ). Put 1 layer of Whatman 3 mm paper on the gel, and 
remove the glass, put one layer of plastic membrane on the gel. Dry the gel at 80 oc for about 2 
h. Put film directly on the gel. Expose the film ovemight at -80°C with intensifying screen. 
Ureamix (6% acrylamide/N,N'-methylenebisacrylamide mix): for 500 ml 
Urea 7M 210 g 
10XTBE 50ml 
30% acrlbis mix 
dH20 
100ml 
to 500 ml 
Filter through 0.2 J..lm filter and keep at 4 oc in dark. 
Isolation oi genomic DNA irom mouse tails 
Cut 2 cm tail. Add 750 f..Ll of 50 mM Tris-HCl (pH8), 100 mM EDTA, 100 mM NaCl, 1% 
SDS, 0.5 mg/ml proteinase K. Incubate at 55 oc ovemight. Mix 5 min on Eppendorf mixer. 
Add 300 J..Ll SM NaCl, Mix 5 min on an Eppendorf mixer. Spin 5 - 10 min 13000 rpm. Take 
750 f..Ll without top phase and pellet to a new tube. Add 500 J..Ll isopropanol, vortex, spin 13000 
rpm for 10 min. Wash the DNA pellet with 1.5 ml 70% ethanol. Dry the pellet in air. Dissolve 
the pellet in 100 - 500 f..Ll TE buffer. 
PCR reaction to amplify DNA fragment from plasmid 
PCR reaction was performed in 100 f..Ll volume. Add 100 ng plasmid DNA, 10 J..Ll of 10xDNA 
polymerase buffer, 0.2 mM dNTP mix, 1 J..Lg each of S'and 3' primer, 150 J..Lmol MgC12, 5 U of 
Taq polymerase and ddH20 to final volume of 100 fll. First denature at 94 oc for 4 min, in each 
cycle denature at 94 oc for 1 min, annealling for 2 min at the temperature 5 oc lower than the 
melting temperature of the primer with the lower melting temperature. Primer extention at 72 'C 
for 1 min. Number of cycles about 25 to 30. The last primer extention time was 10 min. 
PCR reaction to amplify DNA fragment from genomic DNA 
Embryonie visceral endoderm tissue was used for isolation of genomic DNA. 4J..Ll of the 
genomic DNA was digested with BamBI in a 20f..Ll volume. Then take 2fll of the degisted DNA 
for amplification of a genomic DNA fragment that has no Bam HI site by PCR. PCR reaction 
was done in a 20 f..Ll volume in which the following reagents were added: 2 f..Ll of BamHI-
digested genomic DNA, 10 pmol of 5' primer, 10 pmol of 3' primer from the promoter, 2 f..Ll of 
lOxPCR buffer, 0.25 mM dNTPs, 1.5 mM MgC12, and ddH20 to 20 fll. Denature at 94 oc for 
10 min, in each cycle denature at 94 oc for 40 seconds, annealling at the temperature soc lower 
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that the primer with lower temperature for 50 seconds, extention at 72 oc for 1 minlkb, at last 
step extention of primers at 72 oc for 10 min. PCR was done with 40 cycles. 
TA cloning 
DNA fragmentwas amplified from genomic DNA by PCR and cloned into pCRII-TOPO vector 
(Invitrogen) with TA cloning protocol provided by the manufacturer. lf concentration of the 
PCR product is high, 10-20 times dilution is necessary. 
Cell culture 
P19 cell culture: P19 teratocarcinoma cell line was cultured in gelatinized cell culture dishes 
(incubate autoclaved 0.1 %gelatin in PBS in cell culture dishes for 30 min at RT) supplemented 
with alpha medium that contains 10% heat inactivated fatal calf serum, 1% glutamax, 1% non 
essential amina1 acids and 1% penicillin. Cells were cu1tured in a cell culture incubator at 37°C 
with 95% humidity and 5% C02• Cells were split when they reach confluency. 
Cu1ture of F9 cells: F9 cells were cu1tured in ge1atinized cell culture dishes supp1emented with 
Hans's F-12/DMEM (i.e., F-12/Dobecco's 1:1) medium containing 2 mM glutamine, 150 ~ 
mercaptoethanol and 10% fetal bovine serum. Cell cuture condition is the same as that for P 19 
cells. 
DNA transfection with coprecipitates of calcium phosphate and 
DNA: 
Split cells at the density of 5 x 105 cells/9cm dish the day before transfection. Prepare DNA 
precipitates: for each dish, add lOM-g DNA (reporter+intemal contro1+carrier) and ddH20 in a 
sterile Falcon tube in a vo1ume of 225 M-1, and then add 25 M-1 2.5 M CaC12, and then use an 
e1ectric pippet to create air bub1es in the so1ution and meanwhile add 250 M-1 of 2xHBS into the 
tube drop by drop, vortex for 5 seconds, and incubate for 20 min at RT. Before adding 
precipates to cells, vortex the tubes and pipet the precipitates up and down severa1 times in order 
to mix well. Leave DNA precipitates on cells for 12-16 hours (overnight), and wash the 
precipitates with PBS (Mg2+/Ca2+ free) and add new medium. lf any treatment of cells shou1d be 
done, such as treatment of cells with 1 M-M all-trans retinoic acid, do it at this step. Harvest cells 
24 hours or more after washing of precipitates for 1uciferase assy and ß-galactosidase assay. 
Luciferase and ß-gal assay 
Assay of 1uciferase: Wash cells twice in PBS without Ca2+ and Mg2+ carefully since Ca2+ will 
inhibite luciferase activity. Remove all PBS from cultures and keep cutures on ice. Add Iysis 
buffer (500 M-1/lOcm dish) to dishes and rock occasionally to distribute buffer evenly over 
plates. Collect lysate with pipet into precooled Eppendorf tubes. Clear lysate by 5 min 
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centrifugation at 13000 rpm at 4 oc. Transfer 100 fll of the supernatant for determining 
luciferase activity. Measurement is donein a luminometer with automatic injection of Iuciferin 
assay solution of 100 fll and 350 fll of assay buffer. 
Solutions: 
Lysis buffer, 0.1 M Tris acetate pH7.5( dissolve Tris base in ddH20, and adjust 
pH to 7.5 with acetate acid). 
2mMEDTA 
1% Triton X100 
For 100 rnllysis buffer: add 10 rnl IM TrisAcetate, 400 fll 0.5M 
EDTA, 1 rn1100% Triton X100 and dH20 to 100ml. 
Glycylglycine buffer: 25 mM Glycylglycine 
15mMMgS04 
4mMEGTA 
pH7.8 
For 1000 ml, dissolve 3.3g Glycylglycine , 3.69g MgSo4 
EGTA in distilled H20, adjust pH to 7.8. 
and 1.52g 
Luciferin Stock: 1 mM (0.28 mg/rnl) Iuciferin in glycylglycine bufffer, store at -20°C 
in dark. 
Assay buffer(350f..Ll/test): 1 mM DTT 
2mMATP 
in glycylglycine buffer 
For 10 ml, add 100 fll of O.lM DTT and 200fll of O.lM ATP to 9.7 rnl 
glycylglycine buffer. 
Luciferin assay solution (100 fll/test): Dilute Iuciferin stock 1:5 in glycylglycine 
buffer, final concentration: 20nmol/test. 
Assay for beta-galactosidase in solution: Place 50 fll of cell extract ( from the cell extract used 
for luciferase assay) into u-wells, Use extraction buffer for determination of reagent blank. Add 
200 f..Ll of reagent mix. Incubate at 37°C in bacteria or cell incubator. Read A420 ( alternatively 
A405 ) when all of the reactions have developed a clearly visible yellow colour which might take 
about more than 30 min. 
Solutions: 
Sodiumphosphate buffer: O.lM Sodiumphosphate pH7.5 ( 0.082M Na2HP04 + 0.018M 
NaH2P04 ) 
ONPG buffer: 8 mg/ml ONPG (o-nitrophenyl-ß-D-galactopyranoside) in O.lM 
sodiumphosphat buffer 
lOOxMg: O.lM MgC12, 4.5M 2-Mercaptoethanol 
Methods 
Reagent mix(per sample): 175~1 of0.1M Sodiumphosphate 
23~1 of ONPG buffer 
2~1 of 1 OOxMg 
ß-galactosidase staining of cells in culture 
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In order to know how efficient DNA transfection is, it would be necessary to stain cells for ß-
galactosidase activity and count the number of blue cells after transfection of cells with CMV-
lacZ expression vector. Rinse cells with 1 X PBS. Fix for 5 min at 4°C in 2% paraformaldehyde 
(in PBS without Ca2+ and Mg2+). Rinse cells with 1 X PBS 3 - 4 times. Overlay cells with 
staining solution, incubate from 30 min to ovemight at 37°C. Check blue cells under 
microscope. 
Preparation of reagents: Dissolve X-gal in DMSO at 40mg/ml, store at -20°C. Prepare 500mM 
potassium ferrycyanide (K3) in and 500mM potassium ferrocyanide (K4) in PBS (withou Ca2+ 
and Mg2+) and aliquot and store in dark at -20°C. Thaw K4 or K3 only once. Make staining 
solution fresh each time. 6 ml staining solution is enough for 9cm dish. Add reagents in the 
following order (important) to make staining solution: 
X-gal 
K3 
lüml 25ml 50ml 
250~1 625~1 1250~1 
100~1 25~1 500~1 
250~1 
500~1 
500~1 
1000~1 
Add 1 X PBS (Ca2+/Mg2+ free) to the final volumes. 
Total RNA isolation 
final concentration 
1mg/ml 
5mM 
5mM 
2mM 
Isolation of total RNA was done with peqGOLD TriFast™ solution (peQLab Biotechnologie 
GmbH). Wash cells with PBS without Ca2+and Mg2+. Leave plates on ice. Add 6.3 ml peqGold 
TriFast solution to the cells in 9cm dish, and pipet cells up and down several times. Transfer all 
lysate to a 12ml steril Greiner polypropyleve tube. Leave the samples at room temprature for 5 
min. Add 1.26ml chloreform to each tube, vortex 15 seconds. Incubate at RT for 3 -10 min. 
Centrifuge at 12000 rpm at 4 oc for 5min. Transfer 60% the upper aquous phase into a new 
tube. Add 3.15 ml isopropyl alcohol (2-propanol) to each tube. Incubate at RT for 5 -15 min. 
Centrifuge 12000 rpm at 4 oc for 10 min. Wash RNA pellet with 75% ethanol. Dry RNA pellet 
for 5 -10 min (not Ionger than this. Otherwise, RNA can not be dissolved. Dissalve RNA pellet 
in a very small amount (30 to 50 ~1) of DEPC H20. 
Determination of Nucleic acid concentration 
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DNA or RNA so1ution is usually diluted in ddH20 in a 1:200 ratio (2.5~1 DNA solution in 
497.5~1 ddH20). The concentration of the diluted DNAso1ution is measured by its optical 
density (OD) at 260 and 280. The concentration of the original DNA so1ution = OD260 x 10 
~g/~1 and RNA concentrtion = OD260 x 8 ~g/~1. An OD260 = 1 is equivalent to 50 ~g/ml of 
double stranded DNA or 40 ~g/ml RNA or 20 ~g/ml single stranded oligonucleotide. The 
OD280 is used as an indication of the purity of the nucleic acid. 
Northern Blot 
E1ectrophoresis of RNA in horizontal agarase gel: Prepare 1% formaldehyde agarase gel as 
following: melt 0.5 gagarasein 37.7 ml H20 in microwave, cool down to about 60°C, add 5.0 
ml 10xMOPS buffer and 8.2 ml of 37% formaldehyde. Pour this gel solution into a gel chamber 
with appropriate comb. Sampie preparation, add up to 15 ~~ of RNA ( 3- 5 ~g po1yA or 20 ~g 
total RNA ), add 16 ~I of the Sampie Buffer Stock Solution to each RNA sample and 
heat at 65 oc for 10 min, cool on ice, add 4 ~1 RNA Dye Solution, spin, Ioad on to the gel 
which is in lxMOPS buffer. Run the gel under a fume hood with 100 volts at RT. 
Post e1ectrophoresis processing:The gel is photographed while still on the ge1 tray. Put a p1astic 
ruler along the side of the gel. Minimize the exposure of the gel to UV light. Transfer the ge1 
with the tray to a large baking dish contairting distilled H 20. Change the H20 after two min. 
Pour off the dH20 after 5 min and add enough 50 mM NaOH to cover the ge1 well and incubate 
with gentle shaking for 30 min. Pour off the NaOH, add an excess of 100 mM Tris-HCl 
pH7.0. Make three changes of this buffer, 10 min each. Finally soak the gel in 10xSSC for 
5min. Set up capillary b1otting apparatus with layers of 3 layers of Whatman 3MM paper in 
contact with thc transfer buffer ( lOxSSC), the gel, the blotting membrane (nylon membrane: 
Hybond-N+ ), put parafilm around the ge1 to avoid paper towels tauehing whatman paper and 
10xSSC directly, 3 layers of Whatman 3 MM paper, lots of paper towels, heavy books (about 
500 g), make sure that there are no air bubles under the gel, under the b1otting membrane or on 
the top of the blotting membrane. Transfer RNA from gel to membrane overnight with 
10xSSC. 
UV crosslink and prehybridization: Transfer the blotting membrane to a tray of 2xSSC and 
remove any adhesive agarase on the gel. Dry the membrane in air at least for 1 h. Put the RNA 
side to UV light in a Stratalinker device and autocrosslink RNA with the membrane. Transfer 
the membrane back to 2xSSC and then to H20. Use Qui~kHyb solution (Stratagene) for 
prehybridization and hybridization, prehybridize the membrane in 5 or 10 ml QickHyb solution 
at 68 oc for 20 to 30 min. 
Preparation of [a-32PldCTP labe1ed probe: Denature 20- 50 ng DNA template, 95 °C,5 min, 
then on ice. Add denatured DNA in a final volume of 45 ~1 to a Rediprime tube, flick the tube to 
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mix and spin briefly, add 5 111 of [a-32P]dCTP, pipet up and down to mix, spin briefly, 
incubate at 37 °C for 30 min. Purify the probe with QIAGEN Quick Nucleotide Removal Kit. 
Take 1111 of probe for measuring the counts. 
Hybridization: Add the labeled probe to 100111 of 10 mg/ml sonicated salmon sperm DNA, boil 
the double-stranded probe and salmon sperm DNA mixture for 2 min and denature the probe on 
ice. Place the probe into the bag containing prehybridized membrane. Mix the probe in the bag 
well. Hybridize the membrane with the probe at 68 oc for 1 h. 
Wash: Carefully cut one comer of the bag and pour the radioactive solution into radioactive 
waste tank. Wash the membrane in a metal box containing 2xSSCand 0.1 %SDS (2.5 rnl/cm2 
membrane) twice (15 minleach) at RT with gentle agitation. Wash once for 30 min at 60 oc with 
0.1xSSC and 0.1% SDS with gentle agitation. 
Autoradiography: Wrap the membranein a plastic wrap and place the wrapped membrane on 
Kodak X-OMAT AR film with an intensifying screen at -80°C. Expose the film for ovemight to 
sevral days, 
Stripping the membrane for reuse: Heat the 0.1 x SSC and 0.1% SDS wash solution to boiling. 
Pour it over the membranein a metal box. Wash the membrane twice for 15 min. Wrap the wet 
membrane immediately in a plastic wrap for next hybridization. Never Iet the membrane 
get dry if it has to be reprobed. 
Reagents from Stratagene company: 
QuickHyb hybridization solution, Salmon Sperm DNA, 
Solutions: 
10xMOPS 0.2MMOPS 41.85 g/1 
O.OSM Na Acetate 4.1 g/1 
0.01M N~EDTA 20 ml O.SM 
adjust pH to 7.0 
store in a dark bottle or foil wrapped bottle, autoclave 
Sampie Buffer Stock Solution 5 111 of 10mg/ml Ethidium Bromide 
250 111 of Formamide 
RN A Dye Solution 40% sucrose 
50 J.Ll of 10 x MOPS buffer 
80 J.Ll of 37% Formaldehyde 
0.025% Bromophenol blue (6mg/25ml) 
in DEPCH20 
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don 't autoclave 
1M Tris-HCI pH7.0 dissolve Tris base in dH20 and use HCI to adjust pH to 7.0, autoclave. 
Retinoic acid treatment of mouse embryos in utero 
C57BL/6J mice were mated in the evening and plugs were checked 2 hours later. Fertilization 
was assumed one hour after setting up matings. This time point was designated as embryonie 
day 0. When the development of embryos reached E8+5hours or E10.5, 200 ~I of 2.5 mg I ml 
all-trans retinoic acid (Sigma) were administered to pregnant mice by oral gavage. tRA was 
dissolved in DMSO at 25 mg I ml and diluted in sesame oil to 2.5 mglml. Control embryos 
were treated with 200 ~I 10% DMSO in sesame oil. The dosage administered was 20 mg tRA 
per kilogram of body weight. 
Isolation of mouse embryos, fixation, dehydration, embedding and 
sectioning 
Mouse embryos at different stages were isolated in ice cold PBS. Fixation of embryos was done 
in 4% paraformaldehyde ( dissolved in PBS without Ca2+ and Mg2+ ) at 4°C ovemight or at RT 
for 4 h. Dehydration of embryoswas done by changing through PBS, 25% methanol-75% PBS 
( Ca2+1Mg2+ free ), 50% methanol-50% PBS ( Ca2+/Mg2+ free ), 75% methanol-25% PBS( 
Ca2+1Mg2+ ), 100% methanol. Embryos were incubated at each step for 10 min at RT. Store 
dehydrated embryos in methanol at -20°C. 
Infiltrate E 10.5 embryos with ethanol for 1 h, xylene 1 h, xylene 1 h, wax:xylene(l: 1) 1 h and 
wax 1 h. Then embed embryos in wax. Histo wax or Parafin wax was melted at 60°C. 
Sectioning of embroys at thickness of 7 ~m/section was done with a microtome. 
Radioactive in situ hybridization of mouse embryos in sections 
tRA-treated and control embryos were isolated at E10.5. Embryos were fixed in 4% 
paraformaldehyde ovemight at 4 °C, and dehydrated and embedded in parafin. Sagittal sections 
(7~m thick) were subjected to in situ hybridization, following standard procedures ( Brigit 
Hogen ). A 1.2 kb full-length mouse goosecoid cDNA clone (Blum, cell) was used as template 
for synthesis of radioactive a 35S-UTP labeled probes by in vitro transcription. Hybridization 
reactions were performed at 60°C. After development slides were counter stained with 
hematoxilin and eosin. For details, see the radioactive in situ hybridization protocol in the 
supplement of the thesis (see supplement for a detailed protocol). 
Bone and cartilage staining of E17.5 mouse embryos 
tRA-treated and control embryos were harvested at E 17.5 for skeletal analysis. Embryos were 
skinned and eviscerated, and fixed in 100 % ethanol ovemight. Cartilage staining was 
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performed by overnight incubation in 0.015% alcian blue 8 GX (Sigma), dissolved in 80% 
ethanol I 20% acetic acid. After washing of embryos in 100% ethanol for 12 h, they were 
treated with 2% KOH for 6 h, followed by staining with 0.005% alizarinred S (Sigma) in 2% 
KOH overnight. Finally, the embryos were incubated in 2% KOH until they are transparant 
and stored in 25% glycerol-75% ethanol. 
80 Radioactive in situ hybridization 
1. Preparation of slides for carrying tissue sections 
Imerse normal slides in the following solutions step by step: 
10% HCl/70% Ethanol 
ddH20 
96% Ethanol 
Put slides in an oven at 150 oc for 5 to 10 min (not Ionger than 10 min) 
Cool down the slides to RT 
Imerse slides in 2% Tespa (Sigma) in Aceton for 10 sec. 
Slides in 100% aceton for twice. 
Slides in ddH20 
Dry slides ovemight at 42°C 
These slides can be used within two weeks. 
Tespa: 3-Aminopropyltriethoxy-silane, C9H23NC3Si, store at 0 to 4°C 
2. Pre-hybridization 
Bake all the glass containers and racks for 2 hours at 250°C or let them autoclaved to make them 
RNase-free before the experiment. Prepare 22 baked or autoclaved glass containers 
(9.5x7.5x6cm) for the following procedure, each containing 200ml following solution 
respectively. 
Put slides with sections in glass racks. Bach rack can hold 19 slides at most. Incubate the racks 
with sections in each container according to the following schedule. 
1. Xylol 
2. Xylol 
3. 100% Ethanol 
4. 95% Ethanol 
5. 90% Ethanol 
6. 80% Ethanol 
7. 70% Ethanol 
8. 50% Ethanol 
9. 30% Ethanol 
10 minutes 
10min 
2min 
2min 
2 min 
2min 
2min 
2min 
2 min 
10. 0.86% NaCl 5 min ( 6m15M NaCl in 194 ml ddH20 
11. PBS 5 min 
12. 4%PFA in PBS(without Mg2+ & Ca2+) 20 min 
13. PBS 5 min 
14 PBS 5 min 
15. Proteinase K(400Jll of 10mg/ml Prot Kin 200 ml PBS) 7 min 
16. PBS 5 min 
17. 4% PFA in PBS 5 min 
18. PBS 5 min 
19. Acetylation mix 10 min ( 2.5 ml triethanol amine + 200 ml ddH20 + 0.5 ml acetic 
20. PBS 
21. 0.86% NaCl 
22. 30% Ethanol 
23. 50% Ethanol 
24. 70% Ethanol 
25. 80% Ethanol 
26. 90% Ethanol 
27. 95% Ethanol 
28. 100% Ethanol 
5 min 
5 min 
anhydride, make fresh ) 
2 min U se ethanol from step 9 
2 min to step 8 
2 min to step 7 
2 min to step 6 
2 min to step 5 
2 min to step 4 
2 min Use fresh ethanol 
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Air dry , slides are ready for the probe. 
3. Making Radioactive Probe 
Set up a transcription reaction in 20 111 vo1ume: 
41!1 SxTranscription buffer 
2111 200mMDTI ( 
1111 p1acental RNase inhibitor(20-40U/!!1)(a1so called RNA guard) 
41!1 2.5mMNTP(ATP,GTP&CTP rnixture,each at 2.5mM) 
1111 lllg/1!1 Temp1ate(linear cDNA p1asrnid) 
2111 Autoclaved distilled water(dd water) 
81 
1111 T3, T7 orSp6 RNA po1ymerase(20-40U/!!1) for antisense or sense probe(according to the 
temp1ate. 
5!!1 alpha[35S]-UTP(800 Ci/mmo1) 
-> vortex by dipping 
-> spin down quick1y 
-> 37°C/1hour 
3!!1 tRNA( lOmg/rnl) 
3!!1 RNase-free DNase (1-SU/1.!1) 
-> vortex by dipping 
-> spindown quick1y 
-> 37°C/15rnin 
801!1 dd water 
100111 phenol/Ch1oroform( 1: 1) 
-> vortex well 
-> spin 13000rprn/5rnin 
-> transfer upper phase (the aquous 1ayer containing probe) into a new 
tube( -1 001!1), the following steppes will be done in the new tube 
================================================================ 
Ethanol precipitation: 
33!!1 7 .SM Ammoniumacetate(NH40Ac) 
300!!1 100% Ethanol(2-3xVol.) 
-> vortex well 
-> dry ice/lOrnin. 
-> spin 13000rprn/10rnin =>pellet 
-> remove ethano1 carefully with pipette!!! 
Wash the pellet with 1 rnl of70% cold ethanol ( to remove sa1ts) (don't vertex) 
Dry the pellet biefly in air 
Disso1ve the pellet in 50!!1 of lOOmM DTT(100!!11MDTT into 900!!1 ddwater) 
Vortex well, spin down quick1y 
take out 1111 for measurement of radioactivity( disso1ved in 3rnl scintillation cocktail) 
take out 2111 for running a 6% po1yacry1arnide ge1 
store the rest of the probe ( 4 71!1) at -80°C. 
4. Treatment of coverslips 
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Imerse coverslips in Silicone solution (Serva) 
Dry the coverslips at RT 
Imerse the coverslips in 99% ethanol 
Back at 150 oc for 2 h or let them autoclaved. 
5. Hybridization 
Set up 60°C water bath and prepare a good plastic box. Wash the box with 1% SDS and lay 3 
layers of Whatman 3 mm paper on the botterm inside the box. Add premix of 20 ml formamide, 
4 ml20 x SSC (autoclaved) and 16 ml of ddH20 evenly on the paper. 
Hybridization: Add hybridization buffer in a vo1ume of 9 times of the volume of the probe 
to the probe. Mix weil and heat at 80 oc for 3 min and chill on ice immediately. Add 40 Jll to 
each slide. Use a pippet to spread the probe on a slide evenly and cover the slides with a 
pretreated coverslip carefully to try to avoid air bubles btween slides and coverslips. Note, 
forceps used in this step should be flamed before start. It is suggested that 1-2 x 105 cprn/Jll 
count be used. Totalcountper slide is about 4-8 x 106• 
The number of the slides that can be hybridized = Total volume of the probe/ 40 Jll, or Total 
counts of the probe divided by 4-8 x 106. 
Hybridize the slides in the plastic box in water bath at 60 oc ovemight. 
Hybridization buffer: lml 
10 x hybridization salt 
formamide 
50% Dextran sulfate 
1MDTT 
tRNA 
10 x Hybridization Salt: 
PVP ( Polyvinylpyrrolidone ) 
Pieoll 
NaH2P04 pH6.8 
0.5 M EDT A pH8.0 
5 MNaCl 
1M Tris/HCl pH8.0 
add ddH20 to 100 ml, autoclave 
6. Wash 
100 Jll 
500 Jll 
200 Jll 
100 Jll 
1Jll 
0.2 g 
0.2 g 
1.38 g 
10ml 
58.82 ml 
10 Jll 
Remave slides from humid chamber , put them directly into racks. Lable containers especially 
for RNase step. The containers used for washing should not be mixed with other containers. 
Process racks through the following schedule: 
1. 2xSSC/50% Formamide/MeE 15 min, 37°C in water bath with gentle shake 
2. 2xSSC/50% Formamide/MeE 30 min, 65 oc 
3. Transfercontainer from step 2 to 37°C water bath, incubate for 1 to 2 h 
4. NTE 
5. NTE + 20 J.Lglml RN ase A( 40Jll of 1 OOmg/ml RN ase Ato 200 ml NTE) 
6. NTE 
7. 2xSSC/50% Formamide/MeE 
8. 2xSSC 
9. 0.1xSSC 
10. 30% ethanol/0.25 M NH40Ac 
11. 50% ethanol/0.25 M NH40Ac 
12. 70% ethanol/0.25 M NH40Ac 
13. 80% ethanol 
14. 90% ethanol 
15. 95% ethanol 
15 min, 37°C in water bath 
15 min 
15 min 
2min 
2min 
2min 
2min 
2min 
2min 
15 min, 37°C 
15 min, 37°C 
15 min, 37°C 
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16. 100% ethanol 2 min 
17. Air dry, The slides can now be placed into an X -ray cassette and exposed to a normal XAR-
5film. After an ovemight expoure, an extremely faint outline of the section and the signal 
should be visible. This step helps for an overview and an estimation of the background. 
2XSSC/50% Formamide/MeE, for 750 ml, add 
NTE buffer: for 1000 ml, add 
100 m1 of SM NaCl 
10 ml of 1M Tris/HCl pH8.0 
10 m1 of0.5M EDTA pH8.0 
distilled H20 to 1 liter 
375 m1 formamide(lOO%) 
75 m120xSSC 
1 m1 Mercaptoethanol 
distilled H20 to 750 m1 
7. Dip slides in phototoemulsion and autoradiography 
Dilute photoemulsion in distilled warm H20 ( 43 oq in 1: 1 ratio in dark room. Dip slides twice 
in diluted warm photoemulsion (43°C). Dry the slides in air in a dark room. Afterwards wrap 
the slides in a rack and leave the slides at 4 oc for 5-l 0 days exposure. 
8. Develope the slides 
Dissolve 32 g Kodak D 19 Developer in 200 m1 tap water at 36°C, 60 g of Sodium Thiosulfate 
(NazS20 3.5H20, Sigma) in 200 distilled water and 2 ml acetic acid in 200 ml distilled water. 
1. Kodak D 19 solution 
2. 1% acetic acid 
3. Sodium thiosulfate (fixer) 
4. Tap water 
5. Tap water 
6. Tap watrer 
Dry the slides in air 
3 min 
1 min 
5min 
lOmin 
10min 
30min 
9. Hematoxylin and eosin staining 
1. Mayer's Hematoxylin(Sigma) 
2. dH20 
3. 0.02% Eosin(Sigma) 
· 4. 70% ethanol 
5. 100% ethanol 
Dry slides by air 
2min 
5 min 
30 sec 
30 sec 
30 sec 
Lay Entellan on the slides and cover the slides with coverslips. 
Check insitu signal under a microscope with both bright and dark field. 
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6. Abbreviations 
AP-1 
BMP-4 
cDNA 
DMSO 
DNA 
dNTP 
DTT 
EDTA 
E8 +5 h 
E10.5 
et al. 
FCS 
Fig. 
g 
GAPDH 
GTP 
h 
kb 
kg 
1 
M 
mg 
~1 
~ 
mRNA 
nM 
OD 
PBS 
PCR 
RAR 
RARE 
RXR 
RA 
shh 
Activitor -protein-1 
Bone Morphorgenetic Protein 4 
double-strand copy of mRNA 
dimethylsulfate 
desoxyribonucleic acid 
desoxynucleoside triphosphoate 
dithiothreitol 
ethylenediamine-N, N-tetracetate 
embryonie day 8 plus 5 hours 
embryonie 10.5 
and others (lat. et alii) 
fetal calf serum 
figure 
gram 
glyceraldehyde-3-phosphate dehydrogenase 
guanosine triphosphate 
hour 
kilobase ( 1 kb = 1000 bp) 
kilogram 
Iiter 
molar 
milligram 
microliter (10"6 1) 
mieremolar (10.6 molar) 
messenger RNA 
nanomolar (10"9 molar) 
optical density 
phosphate buffered saline 
polymerase chain reaction 
retinoic acid receptor 
retinoic acid response element 
retinoic X receptor 
retinoic acid 
sonic hedgehog 
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tRA all-trans retinoic acid 
9-cis RA 9-cis retinoic acid 
RNA ribonucleic acid 
RT room temperature 
SDS sodium dodecylsulfate 
sec second 
TEMED N,N,N' ,N' -tetramethylethylenediamine 
ZPA zone of polarizing activity in posterior limb bud 
TGF-ß transforming growth factor ß 
TPA 12-0-tetradecanoyl-phorbol-13-acetate 
Tris tris-(hydroxymethyl)-aminomethane 
u unite 
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